dapsone has been researched along with clofazimine in 322 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 128 (39.75) | 18.7374 |
| 1990's | 68 (21.12) | 18.2507 |
| 2000's | 62 (19.25) | 29.6817 |
| 2010's | 53 (16.46) | 24.3611 |
| 2020's | 11 (3.42) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bera, S; Mondal, D | 1 |
| Hentschel, B | 1 |
| Jopling, WH | 3 |
| Waters, MF | 3 |
| Jolliffe, DS | 1 |
| Ambrose, EJ; Chulawalla, RG; Khanolkar, SR | 1 |
| Faber, WR; Leiker, DL | 1 |
| Browne, SG | 3 |
| Girdhar, A; Ramu, G | 1 |
| Candler, ER; Gangadharam, PR | 1 |
| Ellis, BP | 1 |
| Alexander, R; Taylor, PM | 1 |
| Barrett, DF | 1 |
| Jacobson, RR; Trautman, JR | 1 |
| Trautman, JR | 1 |
| Mahapatra, SB; Ramu, G | 1 |
| Dongre, VV; Ganapati, R | 1 |
| Theophilus, S | 1 |
| Iyer, GG; Ramu, G | 1 |
| Leiker, DL | 3 |
| Karat, AB | 2 |
| Dockx, P; Pattyn, SR; Rollier, MT; Rollier, R; Saerens, EJ | 1 |
| Gatti, JC | 1 |
| Beiguelman, B | 1 |
| Ahrens, TF; Glaus, L; Pettit, JH; Ridley, DS | 1 |
| Pfaltzgraff, RE; Steenbergen, GJ | 1 |
| Ala, J; Hall, JJ; Reeve, PA | 1 |
| Cartel, JL; Grosset, JH; Martin, PM; Moulia-Pelat, JP; Nguyen Ngoc, L; Spiegel, A | 1 |
| Bahmer, FA | 1 |
| Kashyap, A; Saha, K; Sehgal, VN | 1 |
| Chakrabarty, AK; Chattopadhya, D; Kashyap, A; Saha, K; Sahu, A | 1 |
| Becx-Bleumink, M | 1 |
| Fiallo, P; Gelber, RH; Gillis, TP; Hill, C; Izumi, S; Job, CK; Williams, DL | 1 |
| Bourland, J; Pattyn, SR | 1 |
| Groenen, G; Janssens, L; Kuykens, L; Mputu, LB; Pattyn, SR | 1 |
| Banerjee, NR; Jagga, CR; Saha, K; Sahu, A; Sehgal, VN | 1 |
| Basson, K; Kriegler, A; van der Walt, BJ; van Zyl, JM | 1 |
| Bulmer, K; Ratledge, C; Wheeler, PR | 1 |
| Britton, WJ; Cho, SN; Failbus, SS; Neupane, KD; Roche, PW; Theuvenet, WJ | 1 |
| Blok, LM; Bloos, LJ; van den Berg, G | 1 |
| Gilbody, JS | 1 |
| Bagga, A; Katoch, K; Katoch, VM; Natarajan, M | 1 |
| Balakrishnan, A; Christian, M; Nagarajan, M; Prabhakar, R; Somasundaram, PR; Thomas, A; Tripathy, SP | 1 |
| Cottenot, F; Flageul, B; Pennec, J; Vignon-Pennamen, MD; Wallach, D | 1 |
| Ellard, GA | 3 |
| Aoyagi, T; Toyoda, T | 1 |
| Bhattacharya, SN; Mathur, RP; Sehgal, VN; Sharma, VK | 1 |
| Ji, F; Li, W; Luo, J; Tao, M; Wang, C; Yang, Z; Ye, G | 1 |
| Katoch, K; Ramanathan, U; Ramu, G | 1 |
| Jidoi, J; Saito, H; Tomioka, H; Yamada, Y | 1 |
| Gharpuray, MB; Kulkarni, DS; Kulkarni, V | 1 |
| Abalos, RM; Cellona, RV; de la Cruz, EC; de Wit, MY; Douglas, JT; Fajardo, TT; Hirsch, DS; Klatser, PR; Madarang, MG | 1 |
| Katoch, K; Katoch, VM; Ramanathan, U; Ramu, G; Sengupta, U; Sharma, VD; Shivannavar, CT | 1 |
| Bourland, J; Ghys, P; Grillone, S; Groenen, G; Pattyn, SR | 1 |
| Deverchin, J; Ghys, P; Groenen, G; Janssens, L; Pattyn, SR | 1 |
| Chatterjee, G; Ganguly, NK; Kaur, S; Sharma, VK; Vaishnavi, C | 1 |
| Pavithran, K | 1 |
| Agarwal, JS; Chopra, NK; Pandya, PG | 1 |
| Bhate, RD; Bhate, RP; Chattopadhyay, SP; Gupta, CM | 1 |
| Baohang, J; Grosset, JH; Noordeen, SK | 1 |
| Chatterjee, BR | 2 |
| Duan, CX; Huang, WB; Li, HY; Ma, JF; Yu, XL; Zhang, MS; Zhang, SB; Zhu, K | 1 |
| Ekambaram, V; Rao, MK | 1 |
| Bach, MA; Garraud, O; Ribierre, O | 1 |
| Bhatia, VN; Chandrasekaran, V; Hari, L; Kumar, A; Nagarajan, M; Prabhakar, R; Roy, RG; Somasundaram, PR; Thomas, A | 1 |
| Li, WZ | 1 |
| Dharmshaktu, NS; Mittal, BN; Rao, CK | 1 |
| Christian, M; Ellard, GA; Jesudasan, K; Pannikar, VK | 1 |
| Dutta, RK; Singh, G; Tiwari, VD; Tutakne, MA | 1 |
| Bourée, P; Carré, N; Drahmane, S | 1 |
| Ganguly, NK; Kaur, H; Kaur, S; Sharma, VK; Vaishnavi, C | 1 |
| Aggarwal, SK; Arora, PN; Ramachandra, S; Ramakrishnan, KR | 1 |
| Baohong, J; Colston, MJ; Matsuo, Y | 1 |
| Pieters, FA; Woonink, F; Zuidema, J | 1 |
| Ye, GY | 1 |
| Balakrishnan, S; Bhatia, VN; George, J | 1 |
| Chaudhury, S; Chaudhury, SN; Das, PK; Hazra, S; Majumder, V; Poddar, S; Podder, GC; Sarkar, S | 1 |
| Floch, HA | 1 |
| Levy, L | 2 |
| Bach, MA; Cottenot, F; Flageul, B; Hoffenbach, A; Wallach, D | 1 |
| Bhatia, VN; Harikrishnan, S; Kar, HK | 1 |
| Pattyn, SR | 2 |
| Bahmer, FA; Menzel, S | 1 |
| Onsun, N; Pattyn, SR; Saylan, T | 1 |
| Martinez Cruz, D | 1 |
| Gandhi, IS; Mehta, J; Sane, SB; Wamburkar, MN | 1 |
| Andrade, VL; Avelleira, JR; da Cunha, LH; Marques, AB | 1 |
| Coussens, L; Groenen, G; Janssens, L; Kayembe, T; Nollet, E; Pattyn, SR | 1 |
| Chaturvedi, VN; Jain, SK; Raizada, RM; Rathi, SS | 1 |
| Becx-Bleumink, M; van Asbeck-Raat, AM | 1 |
| Bharadwaj, VP; Girdhar, BK; Mathur, A; Venkatesan, K | 1 |
| Anderson, R | 2 |
| Ffytche, TJ; McDougall, AC | 1 |
| Ji, BH | 1 |
| Ganapati, R; Maniar, JK; Parikh, AC; Parikh, DA | 1 |
| Rook, GA | 1 |
| Adiga, RB; Fairbairn, T; Samual, S; Samuel, NM | 1 |
| Choi, YS; Good, RA; Jacobson, RR; Kiszkiss, DF; Lim, SD | 1 |
| Freerksen, E; Rosenfeld, M | 1 |
| Shepard, CC | 1 |
| Desikan, KV; Ramu, G; Sengupta, U | 1 |
| Chaudhury, S; Ghosh, S; Hazra, S; Kundu, SK | 1 |
| Ramu, G | 1 |
| Jones, RL; McDougall, AC | 1 |
| Sansarricq, H | 1 |
| Appa Rao, AV; Krishna, DR; Prabhakar, MC; Ramanakar, TV | 1 |
| Moschella, SL | 1 |
| Bourland, J; Davies, EM; Feracci, C; Grillone, S; Janssens, L; Pattyn, SR; Saylan, T | 1 |
| Keeler, RF | 1 |
| Pruzanski, W; Saito, S | 1 |
| Bonhomme, J; Chalopin, JM; Lucht, F; Portier, H; Rifle, G | 1 |
| Riley, DN | 1 |
| Ganapati, R; Naik, SS; Revankar, CR | 1 |
| Bumb, RA; Mangal, HN; Mathur, NK | 1 |
| Bulakh, PM; Burte, NP; Chandorkar, AG; Kowale, CN; Ranade, SM | 1 |
| Brown, KE; McDougall, AC; Winsley, BE | 1 |
| Beeching, NJ; Ellis, CJ | 1 |
| Brazin, SA | 1 |
| Rees, RJ | 1 |
| Lang, WR | 1 |
| Anderson, R; Gatner, EM; Imkamp, FM; van Rensburg, CE | 1 |
| Anderson, R; Gatner, EM; Imkamp, FM | 1 |
| Dubois, EL; Jakes, JT; Quismorio, FP | 1 |
| Paul, S; Rose, ET | 1 |
| Seshadri, PS | 1 |
| Imkamp, FM | 1 |
| Gidoh, M; Takitani, S; Tsutsumi, S | 1 |
| Chaubey, BS; Dubey, GK; Hardas, UD; Joglekar, VK | 1 |
| Bharadwaj, VP; Desikan, KV; Ramu, G; Venkatesan, K | 1 |
| Dutta, RK | 1 |
| Choudhury, HS; Chowdappa, J; Vasireddi, SS | 1 |
| Dang, DT; Ho, ML; Hoang, TL; Le, TH; Le, TP; Nguyen, DH; Nguyen, DQ; Nguyen, QA; Tran, HK; Vu, TT | 1 |
| Altes-Levy, HR; Chin-a-Lien, RA; Naafs, B | 1 |
| Difonzo, EM; Farella, V; Lotti, T; Panconesi, EX | 1 |
| Grosset, JH; Ji, B; N'Deli, L; Perani, EG; Petinom, C | 1 |
| Jackson, T | 1 |
| Chularatna, W; Mendis, S; Somasiri, KG | 1 |
| Andreoli, A; Kohn, A; Luzi, C; Mangiarotti, R; Prantera, C | 1 |
| Oommen, T; Tyagi, PY | 1 |
| Dekio, S; Saito, H; Sato, K; Tomioka, H | 1 |
| Denis, P; Ghys, P; Janssens, L; Karibushi, N; Kuykens, L; Pattyn, SR; Tshilumba, K | 1 |
| Beena, KR; Kar, HK; Misra, RS; Mukherjee, A; Mukherjee, R; Nair, NS; Parida, SK; Sharma, AK; Walia, R; Zaheer, SA | 1 |
| Danziger, LH; Fischer, JH; Hill, C; Occhipinti, DJ; Piscitelli, SC; West, DP | 1 |
| Li, HY | 1 |
| Cartel, JL; Chanteau, S; De Bruyn, J; De Cock, M; Drowart, A; Huygen, K; Launois, P; Van Vooren, JP; Yernault, JC | 1 |
| Lim, JT; Tan, T | 1 |
| Ganguly, NK; Kaur, S; Kohli, MM; Sharma, VK | 1 |
| Kaplan, G; Malta, AM; Sampaio, EP; Sarno, EN | 1 |
| Beijnen, JH; Hoetelmans, RM; Koks, CH; Otten, JM; Soesan, M | 1 |
| Anadolu, R; Erdi, H; Gürgey, E; Pişkin, G | 1 |
| Ramachandran, A; Rao, PS; Ravi, S; Sekar, B; Subramanian, M | 1 |
| Bhargava, P; Kuldeep, CM; Mathur, NK | 1 |
| Antia, NH; Shetty, VP; Uplekar, MW | 1 |
| Cottenot, F; de Carsalade, GY; Flageul, B; Pennec, J; Spindler, E; Wallach, D | 1 |
| Pavithran, K; Satish, TC | 1 |
| Carvalho, D; Gouveia, EG; Melchior, E; Queiroz, RH; Souza, AM | 1 |
| Arunthathi, S; Satheesh, KK | 1 |
| Barbosa, JC; de Carvalho, D; de Souza, AM; Gouveia, E; Melchior Júnior, E; Queiroz, RH | 1 |
| Maw, WW; Saito, H; Sato, K; Tomioka, H | 1 |
| Banerji, U; Ganapati, R; Pai, VV; Saha, B; Thomas, J | 1 |
| Casado, JL; Chinchón Lara, I; Creagh, R; Gálvez, J; López-Domínguez, JM; Navarro, A | 1 |
| Ji, B | 1 |
| Arra, GS; Arutla, S; Krishna, DR; Prabhakar, CM | 1 |
| Barral, A; Barral-Netto, M; Bittencourt, AL; Carvalho, EM; Santos, I; Santos, S; von Sohsten, R; Waters, M | 1 |
| Ganapati, R; MacLean, S; Pai, VV; Prange, H; Stietenroth, K | 1 |
| Ahern, KP; Cabrera, A; Levis, WR; Vides, EA | 1 |
| al-Suwaid, AR; Mysore, V | 1 |
| Krishna, KK | 1 |
| Kar, HK; Kaur, H; Misra, RS; Mukherjee, A; Mukherjee, R; Rani, R; Sharma, P | 1 |
| LeMaster, JW; Manandhar, R; Roche, PW | 1 |
| Abraham, S; Arunthathi, S; Ebenezer, GJ; Job, A; Job, CK; Rao, PS | 1 |
| Chopra, I; Comanducci, A; Oliva, B | 1 |
| Elston, DM; Gilson, RT; Young, RJ | 1 |
| Hsu, S; Winter, CA | 1 |
| Chauhan, DS; Gupta, UD; Katoch, K; Katoch, VM; Natrajan, M; Sharma, RK; Sharma, VD; Singh, D; Singh, HB; Srivastava, K | 1 |
| Boisseau-Garsaud, AM; Garsaud, P; Helenon, R; Quist, D; Saint-Cyr, I; Vezon, G | 1 |
| Balasundaram, B; Ebenezer, G; Natrajan, MM; Rao, GS; Shaw, IN | 1 |
| Barquin, L; Burdick, AE; Elgart, GW; Hendi, A; Scollard, DM | 1 |
| Butlin, CR; Failbus, SS; Neupane, KD; Roche, PW | 1 |
| Middleton, JR; Ranjan, R; Sen, P | 1 |
| Baxt, RD | 1 |
| Christian, M; Jesudasan, K; Kavitha, M; Natrajan, MM; Rao, GS; Shaw, IN | 1 |
| Kashiwabara, Y; Matsuoka, M; Namisato, M | 1 |
| Lockwood, DN; Marlowe, SN | 1 |
| Kalpana, T; Karunakar, N; Krishna, DR; Prabhakar, MC; Reddy, MS | 1 |
| Ramos-e-Silva, M; Rebello, PF | 1 |
| Janner, D; Prince, JM | 1 |
| Bassetti, C; Siccoli, M | 1 |
| Alto, WA | 1 |
| Costa Queiroz, RH; de Souza, AM; Melchior, E; Sampaio, SV | 1 |
| Anandan, D; Arunagiri, K; Elangeswaran, N; Jayarama, E; Kumar, SS; Rajendran, M; Sekar, B; Vijayaraghavan, R | 1 |
| Agrawal, US; Meena, RS; Saini, M; Saxena, A; Saxena, V | 1 |
| Lockwood, D | 1 |
| Joyce, MP; Longfield, RN; Murray, CK | 1 |
| Christian, M; Jesudasan, K; Kurian, N; Rao, GS; Shaw, IN | 1 |
| Abalos, RM; Balagon, MV; Cellona, RV; Dela Cruz, EC; Fajardo, TT; Tan, EV; Villahermosa, LG; Walsh, DS; Walsh, GP | 1 |
| Alioua, Z; Benomar, S; Boudi, O; Bouzidi, A; Elhaouri, M; Ghfir, M; Sbai, M; Sedrati, OL | 1 |
| Aranda, J; Cohen, JB; Hoang, MP | 1 |
| Joseph, G; Norman, G; Richard, J | 1 |
| Gupta, UD; Katoch, K; Katoch, VM; Natrajan, M; Sharma, VD; Shivanavar, CT | 1 |
| Gandhi, G; Singh, B | 1 |
| Biswas, SK | 1 |
| Alves-Rodrigues, EN; Fontes, CJ; Ribeiro, LC; Silva, MD; Takiuchi, A | 1 |
| Armour, KS; Barnetson, RS; Scolyer, RA | 1 |
| Borges, AS; De Rezende, TM; Ferreira, MS; Goulart, IM; Nishioka, SA; Reis, AC | 1 |
| Helling, CA; Locursio, A; Manzur, ME; Sormani de Fonseca, ML | 1 |
| Alves-Rodrigues, EN; Fontes, CJ; Martini-Filho, D; Rabel-Filho, OC; Ribeiro, LC; Silva, MD; Takiuchi, A | 1 |
| Bahloul, Z; Feki, I; Jlidi, R; Mhiri, C; Miladi, MI | 1 |
| Al-Raqum, HA; El Abdalghani, RA; Lasheen, I; Uppal, SS | 1 |
| Roca, B | 1 |
| Ho, CK; Lo, KK | 1 |
| Gidoh, M; Goto, M; Hatano, K; Ishida, Y; Ishii, N; Nogami, R; Okano, Y; Ozaki, M | 1 |
| Firooz, A | 1 |
| Burns, J | 1 |
| Arif, MA; Manglani, PR | 1 |
| Courtright, P; Lewallen, S | 1 |
| Arora, SK | 1 |
| Flageul, B; Gaulier, A; Ighilahriz, O; Ingen-Housz-Oro, S; Levy-Weil, F; Meyer, M; Sigal-Grinberg, M; Wendling, J | 1 |
| Birshner, Rde C; Deps, PD; Guerra, P; Nasser, S; Rodrigues, LC; Simon, M | 1 |
| Illarramendi, X; Jardim, MR; Nascimento, OJ; Nery, JA; Sales, AM; Sampaio, EP; Sarno, EN | 1 |
| Concha R, M; Cossio T, ML; Fich S, F; González B, S; Pérez C, C; Salazar S, I | 1 |
| Gupte, MD; Htoon, MT; Jadhav, V; Jamesh, A; Jianping, S; Katoch, K; Krishnamurthy, P; Kroger, A; Manickam, P; Pannikar, V; Ramalingam, K | 1 |
| Abide, JM; Jones, HL; Webb, RM; Young, L | 1 |
| Catorze, MG; Medeiros, S; Vieira, MR | 1 |
| Aricò, M; Bongiorno, MR; Noto, S; Pistone, G | 1 |
| Andre, P; Camu, W; Flageul, B; Gabelle, A; Vallat, JM | 1 |
| Arenas, R; Asz-Sigall, D; López-García, L; Neme-Yunes, Y; Vega-Memije, ME; Yuen-Palos, R | 1 |
| Beylot, C; Ezzedine, K; Longy-Boursier, M; Malvy, D | 1 |
| Dytoc, M; Kalisiak, M; Yeung, R | 1 |
| Manifold, R; Marshman, G | 1 |
| Pandey, B; Sapkota, BR; Shrestha, K; Walker, SL | 1 |
| Antunes, CM; Borges, VO; Bretas, TL; Costa, RD; Lyon, S; Mendonça, VA; Penido, RA; Teixeira, AL; Teixeira, MM | 1 |
| Becker, L; Kowalewski, C; Martin, JM | 1 |
| Guedes Filho, G; Guedes, WR; Oliveira, BB; Oliveira, CA; Oliveira, DA; Silva, IM | 1 |
| Arvind, C; Sheetal, S | 1 |
| Ladizinski, B; Levis, WR; Spencer, TI | 1 |
| Agarwal, V; Chauhan, S; Wakhlu, A | 1 |
| Bonsmann, G; Kuhn, A; Ruland, V | 1 |
| Dey, V; Dulhani, N; Nel, B; Singh, H; Tiwari, P | 1 |
| Arunagiri, K; Kumar, BN; Menaka, K; Narayanan, S; Oommen, PK; Sekar, B | 1 |
| Balagon, M; Maghanoy, A; Mallari, I; Saunderson, P | 1 |
| Abalos, RM; Balagon, M; Cellona, RV; Ravanes, JM; Walsh, DS; Walsh, GP | 1 |
| Dacso, MM; Jacobson, RR; Prestigiacomo, JF; Scollard, DM; Stryjewska, BM | 1 |
| Crosti, C; Cusini, M; Marzano, AV; Massone, C; Nunzi, E; Tosi, D | 1 |
| Aftab, H; Bygbjerg, IC; Due, E; Nielsen, SD; Nielsen, SL; Thybo, S | 1 |
| Dofitas, BL; Yuchua-Guillen, A | 1 |
| Chakma, JK; Girdhar, A; Hussein, S; Malaviya, GN | 1 |
| Adar, T; Barak, O; Mizrahi, M; Shalit, M; Tavdi, S; Tayer-Shifman, O | 1 |
| Akama, T; Degang, Y; Gidoh, M; Hara, T; Ishido, Y; Ishii, N; Makino, M; Suzuki, K; Tanigawa, K | 1 |
| Almeida, PC; Bührer-Sékula, S; Cruz, R; Gonçalves, Hde S; Moraes, ME; Penna, GO; Pontes, MA | 1 |
| Cunha, Mda G; Lockwood, DN | 1 |
| Avelleira, JC; Campos, AA; Cruz, RC; Cunha, Mda G; Filho, B; Ghuidella, C; Schettini, AP; Ura, S; Viana, Fdos R; Virmond, M | 1 |
| Deps, P; Guerra, P; Nasser, S; Simon, M | 1 |
| Göttig, S; Weberschock, T | 1 |
| Benchikhi, H; Chiheb, S; Hali, F; Rifki, A; Tirhazouine, I | 1 |
| Ker, KJ; Lui, NL; Pan, JY; Tey, HL | 1 |
| Levin, NA; Makredes, M; O'Donnell, P; Yang, S | 1 |
| Batista Júnior, J; Borges, RS; Coleman, MD; Monteiro, MC; Oliveira, FR; Romão, PR; Salgado, CG; Schalcher, TR; Vieira, JL | 1 |
| Ait Ourhroui, M; El Morabite, K; Hassam, B; Senouci, K; Tbatou, F | 1 |
| Abhinav, C; Chander, B; Chauhan, PS; Khatri, G; Mahajan, VK; Mehta, KS; Prabha, N; Sharma, SK; Sharma, V; Tuli, R | 1 |
| Conerly, S; Marcos, LA; Walker, S | 1 |
| Li, J; Shen, J; Yan, L; Yu, M; Yu, X; Zhang, G | 1 |
| Afzalimoghadam, M; Daneshbod, Y; Eilami, O; Mirfazaelian, H | 1 |
| Fu, X; Liu, H; Zhang, F | 1 |
| Han, XY; Quintanilla, M | 1 |
| Aubry, A; Cambau, E; Reibel, F | 1 |
| Kim, JS; Kwon, SH; Shin, JY | 1 |
| Cardoso, J; Coelho de Sousa, V; Laureano, A | 1 |
| Ozturk, Z; Tatliparmak, A | 1 |
| Bharucha, T; Lockwood, D | 1 |
| Aerts, A; Kawuma, J; Kita, E; Saunderson, P; Smith, CS; Virmond, M | 1 |
| Barreto, ML; Bührer-Sékula, S; Costa, MB; Cruz, R; de Andrade, ARC; de Araújo, MG; Gonçalves, HS; Kerr, LRS; Penna, GO; Penna, MLF; Pontes, MAA; Ramos, AMC; Rodrigues, LC; Rosa, PS; Stefani, MMA | 1 |
| Bass, M; Foster, K; Studdiford, J | 1 |
| Fischer, M | 1 |
| Daga, S; Kumavat, S; Pawar, M; Zawar, V | 1 |
| Sharma, PK; Singh, DK | 1 |
| Barreiros, L; Chaves, LL; Costa Lima, SA; Ferreira, D; Reis, S; Sarmento, B; Segundo, MA; Vieira, ACC | 1 |
| Bührer-Sékula, S; Cruz, RCDS; Gonçalves, HS; Moraes, MEA; Penna, GO; Penna, MLF; Pontes, MAA; Stefani, MMA; Talhari, S | 1 |
| Stock, I | 1 |
| Barreiros, L; Chaves, LL; Fernandes, SR; Lima, SAC; Machado, S; Reis, S; Segundo, MA; Silva, EMP | 1 |
| Araujo, S; Scollard, D; Stryjewska, BM; Williams, DL | 1 |
| Kofler, L; Müller, A; Wolfsperger, F; Yazdi, AS | 1 |
| Bao, F; Cao, J; Cao, Q; Chai, Z; Chen, S; Cheng, X; Chu, T; Duan, Q; Fu, F; Fu, X; Irwanto, A; Ke, W; Krismawati, H; Kuang, Y; Lang, X; Li, J; Li, L; Li, M; Li, W; Lin, Z; Liu, D; Liu, H; Liu, J; Liu, Q; Mi, Z; Ning, Y; Pan, Q; Shang, X; Shen, J; Shen, Y; Sun, L; Sun, Y; Wang, C; Wang, H; Wang, L; Wang, X; Wang, Y; Wang, Z; Wu, W; Xiao, B; Xiao, P; Xiong, F; Xiong, J; Xiong, L; Xiong, M; Xu, Y; Yan, L; Yang, B; Yang, J; You, J; Yu, G; Yu, W; Yue, Z; Zhan, X; Zhang, F; Zhang, G; Zhang, H; Zhang, L; Zhang, Y; Zhao, Q; Zhao, W; Zheng, H | 1 |
| Duran Merino, CE; Jaramillo, MJ; Ortiz Úsuga, MC; Rodríguez, AM | 1 |
| George, J | 1 |
| Bartos, G; Combs, A; Rivlin, D; Sheuring, R | 1 |
| An, HK; Kivela, P; Lee, JH; Oh, S; Sohn, MG | 1 |
| Bidari-Zerehpoosh, F; Bizaval, Z; Mozafari, N; Niknejad, N; Robati, RM | 1 |
| Irwan, ID; Irwanto, A; Krismawati, H; Liu, H; Liu, J; Maladan, Y; Oktavian, A; Pongtiku, A; Sitanggang, YA; Sun, Y; Tanjung, R; Wahyuni, T; Zhang, F | 1 |
| Hacker, MAVB; Illarramendi, X; Maia, RC; Moraes, MO; Nery, JAC; Sales, AM; Sarno, EN | 1 |
| Barroso, DH; Bezerra, NVF; Cerqueira, SRPS; Collin, SM; Cunha, DV; Deps, PD; Gomes, CM; Kurizky, PS; Pillegi, GS; Pinheiro, ABS; Repsold, TAR | 1 |
| Biswas, A; Chakraborty, A; Ghosh, R | 1 |
| Chew, R; Woods, ML | 1 |
| Bao, F; Chen, J; Dong, Y; Fan, Y; Gao, L; Ji, Z; Kong, J; Li, B; Liu, A; Liu, M; Luo, S; Ma, W; Peng, L; Song, J; Wu, X; Yang, J | 1 |
32 review(s) available for dapsone and clofazimine
| Article | Year |
|---|---|
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Leprosy reactional states and their treatment.
Topics: Antigen-Antibody Complex; Clofazimine; Dapsone; Humans; Immunity, Cellular; Leprosy; Prednisolone; Thalidomide | 1977 |
Chemotherapy in Leprosy.
Topics: Acetamides; Anemia, Hemolytic; Aniline Compounds; Animals; Clofazimine; Dapsone; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Leprosy; Methimazole; Mice; Mycobacterium leprae; Phenyl Ethers; Rifampin; Sulfonamides; Thiosemicarbazones; Thiourea | 1975 |
[Leprosy therapy and pharmacogenetics (author's transl)].
Topics: Acetyltransferases; Clofazimine; Cytochrome-B(5) Reductase; Dapsone; Glucosephosphate Dehydrogenase; Humans; Leprosy; Molecular Biology; Pharmacogenetics; Polymorphism, Genetic; Sulfonamides; Thiosemicarbazones; Time Factors | 1975 |
Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational proced
Topics: Clofazimine; Dapsone; Epidemiologic Methods; Ethiopia; Humans; Incidence; Leprostatic Agents; Leprosy; Leprosy, Borderline; Leprosy, Lepromatous; Leprosy, Tuberculoid; Recurrence; Rifampin | 1992 |
Chemotherapy of leprosy.
Topics: Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprosy; Rifampin | 1988 |
Screening of drugs for activity against Mycobacterium leprae.
Topics: Animals; Clofazimine; Dapsone; Drug Evaluation, Preclinical; Leprostatic Agents; Leprosy; Mice; Mycobacterium leprae; Rifampin; Thioamides | 1987 |
Drug resistance in leprosy--a review.
Topics: Animals; Clofazimine; Dapsone; Drug Resistance, Microbial; Ethionamide; Humans; Leprosy; Mice; Microbial Sensitivity Tests; Rifampin | 1985 |
Growing points in leprosy research. 4. Recent advances in the chemotherapy of leprosy.
Topics: Clofazimine; Dapsone; Ethionamide; Humans; Leprosy; Rifampin; Sulfonamides; Thioacetazone; Thiourea | 1974 |
The first decade in experimental leprosy.
Topics: Animals; BCG Vaccine; Clofazimine; Dapsone; Disease Models, Animal; Drug Evaluation; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Humans; Leprosy; Mice; Mycobacterium leprae; Radiation Effects; Rifampin; Thymectomy | 1971 |
Evolution of the modern chemotherapy of leprosy.
Topics: Animals; Clofazimine; Dapsone; Drug Evaluation; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Mycobacterium leprae; Recurrence; Rifampin | 1983 |
Recent changes in leprosy control.
Topics: Bacterial Vaccines; Clofazimine; Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Mycobacterium leprae; Rifampin; World Health Organization | 1983 |
The immunopharmacology of antileprosy agents.
Topics: Antigens, Bacterial; Clofazimine; Dapsone; Erythema Nodosum; Humans; Immune Tolerance; Immunity, Cellular; Leprostatic Agents; Leprosy; Lymphocyte Activation; Mycobacterium leprae; Neutrophils; Rifampin | 1983 |
Leprosy (Hansen's disease).
Topics: Clofazimine; Dapsone; Ear Deformities, Acquired; Humans; Leprosy; Mouth Diseases; Nose Deformities, Acquired; Rifampin; Thalidomide | 1982 |
Update on leprosy.
Topics: Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Mycobacterium leprae; Peripheral Nervous System Diseases; Rifampin | 2001 |
Leprosy.
Topics: Clofazimine; Cost-Benefit Analysis; Dapsone; Drug Therapy, Combination; Global Health; Humans; International Cooperation; Leprostatic Agents; Leprosy; Mycobacterium Infections; Mycobacterium leprae; Prevalence; Rifampin; World Health Organization | 2001 |
Leprosy. Recognition and treatment.
Topics: Adolescent; Adult; Age Factors; Biopsy; Child; Clinical Trials as Topic; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Leprosy; Leprosy, Borderline; Leprosy, Lepromatous; Leprosy, Tuberculoid; Male; Multicenter Studies as Topic; Peripheral Nerves; Rifampin; Skin; Time Factors; World Health Organization | 2001 |
Leprosy.
Topics: Bacterial Vaccines; BCG Vaccine; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Mycobacterium leprae; Rifampin | 2002 |
[Histoid leprosy with erythema nodosum leprosum].
Topics: Adult; Clofazimine; Dapsone; Erythema Nodosum; Fluoroquinolones; Histiocytes; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Mycobacterium leprae; Rifampin | 2003 |
A overview of ocular leprosy after 2 decades of multidrug therapy.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Eye Infections, Bacterial; Global Health; Humans; Leprostatic Agents; Leprosy; Mycobacterium leprae; Rifampin | 2007 |
[Hansen's disease: case report and review of literature].
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Mycobacterium leprae; Rifampin; Treatment Outcome | 2008 |
Arthritis in leprosy.
Topics: Arthritis; Clofazimine; Dapsone; Diagnosis, Differential; Humans; Leprostatic Agents; Leprosy; Mycobacterium leprae; Rifampin | 2010 |
Cutaneous lupus erythematosus: update of therapeutic options part II.
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Clofazimine; Cyclophosphamide; Cyclosporine; Dapsone; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-alpha; Isoxazoles; Leflunomide; Lenalidomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Retinoids; Rituximab; Thalidomide; Tumor Necrosis Factor-alpha | 2011 |
Update on the epidemiology, diagnosis, and treatment of leprosy.
Topics: Antibodies, Bacterial; Bacteriological Techniques; Biopsy; Clofazimine; Dapsone; Drug Resistance, Bacterial; Drug Utilization; Genome, Bacterial; Global Health; History, 16th Century; History, 17th Century; History, 18th Century; History, Ancient; Humans; Leprostatic Agents; Leprosy; Molecular Diagnostic Techniques; Mycobacterium leprae; Phylogeny; Prevalence; Rifampin; Risk Factors | 2015 |
Leprosy treatment during pregnancy and breastfeeding: A case report and brief review of literature.
Topics: Adult; Breast Feeding; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; Leprosy, Multibacillary; Pregnancy; Pregnancy Complications, Neoplastic; Rifampin; Time Factors; Treatment Outcome | 2017 |
Multidrug therapy for leprosy: a game changer on the path to elimination.
Topics: Clofazimine; Dapsone; Disease Eradication; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Mycobacterium leprae; Rifampin | 2017 |
Leprosy - an overview of clinical features, diagnosis, and treatment.
Topics: Adult; Aged; Child; Clofazimine; Cross-Sectional Studies; Dapsone; Disease Progression; Drug Administration Schedule; Female; Guideline Adherence; Humans; Immunity, Cellular; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Leprosy, Tuberculoid; Long-Term Care; Male; Neglected Diseases; Rifampin | 2017 |
Leprosy – an old infectious disease with unsolved matters.
Topics: Animals; Armadillos; Clofazimine; Cross-Sectional Studies; Dapsone; Disease Reservoirs; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Rifampin | 2016 |
Chronic Unilateral Uveitis as a Manifestation of Leprosy: A Case Report and Literature Review.
Topics: Aged; Atrophy; Biopsy; Chronic Disease; Clofazimine; Dapsone; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Iris; Leprostatic Agents; Leprosy, Lepromatous; Macular Edema; Male; Mycobacterium leprae; Rifampin; Skin; Tomography, Optical Coherence; Uveitis, Anterior | 2021 |
Metabolism and interactions of antileprosy drugs.
Topics: Acedapsone; Biological Availability; Biotransformation; Clofazimine; Cytochrome P-450 CYP3A; Dapsone; Drug Interactions; Drug Therapy, Combination; Half-Life; Humans; Leprostatic Agents; Leprosy; Metabolic Clearance Rate; Metabolic Networks and Pathways; Mycobacterium leprae; Rifampin | 2020 |
Treatment of histoid leprosy: a lack of consensus.
Topics: Clofazimine; Consensus; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy | 2020 |
Seventy years of evidence on the efficacy and safety of drugs for treating leprosy: a network meta-analysis.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Leprosy, Multibacillary; Network Meta-Analysis; Rifampin | 2023 |
46 trial(s) available for dapsone and clofazimine
| Article | Year |
|---|---|
A statistical analysis of two chemotherapy trials in lepromatous leprosy. I. The response to therapy as measured by inoculation of mice.
Topics: Adolescent; Adult; Aged; Animals; Clinical Trials as Topic; Clofazimine; Dapsone; Female; Humans; Leprosy; Male; Mice; Middle Aged; Mycobacterium leprae; Regression Analysis; Rifampin; Skin | 1978 |
A statistical analysis of two chemotherapy trials in lepromatous leprosy. II. Interactions among patient variables.
Topics: Adolescent; Adult; Age Factors; Aged; Cell Count; Clinical Trials as Topic; Clofazimine; Dapsone; Female; Humans; Leprosy; Male; Middle Aged; Mycobacterium leprae; Rifampin; Sex Factors; Skin; Statistics as Topic | 1978 |
Evaluation of treatment of lepromatous leprosy patients in the Netherlands.
Topics: Clinical Trials as Topic; Clofazimine; Dapsone; Drug Evaluation; Humans; Leprostatic Agents; Leprosy; Netherlands; Phenylthiourea; Recurrence; Rifampin; Time Factors | 1979 |
Spaced clofazimine therapy of lepromatous leprosy.
Topics: Adolescent; Adult; Aged; Biopsy; Clofazimine; Dapsone; Drug Evaluation; Female; Humans; Leprosy; Male; Middle Aged; Mycobacterium leprae; Skin; Skin Pigmentation | 1976 |
Long-term follow-up of clofazimine (Lamprene) in the management of reactive phases of leprosy.
Topics: Clinical Trials as Topic; Clofazimine; Dapsone; Female; Follow-Up Studies; Humans; Leprosy; Pregnancy | 1975 |
A controlled clinical trial of continuous and intermittent rifampicin therapy during an initial three months period in lepromatous leprosy: final analysis.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Clofazimine; Dapsone; Female; Humans; Leprosy; Male; Middle Aged; Rifampin; Time Factors | 1975 |
Combined therapy in leprosy.
Topics: Adult; Clinical Trials as Topic; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Rifampin | 1975 |
Treatment of multibacillary leprosy with a regimen of 13 weeks duration.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Ethionamide; Humans; Leprostatic Agents; Leprosy; Prospective Studies | 1992 |
Controlled clinical trial of two multidrug regimens with and without rifampin in highly bacilliferous BL/LL south Indian patients: a five-year report.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Isoniazid; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Male; Randomized Controlled Trials as Topic; Rifampin | 1990 |
Pyrazinamide as a part of combination therapy for BL and LL patients--a preliminary report.
Topics: Adolescent; Adult; Animals; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Isoniazid; Leprosy; Male; Mice; Middle Aged; Muscle, Smooth; Pyrazinamide; Rifampin; Scrotum; Skin; Thioacetazone | 1988 |
Combined regimens of one year duration in the treatment of multibacillary leprosy--I. Combined regimens with rifampicin administered during one year.
Topics: Clinical Trials as Topic; Clofazimine; Cohort Studies; Dapsone; Drug Administration Schedule; Ethionamide; Female; Humans; Leprostatic Agents; Leprosy; Male; Rifampin | 1989 |
Combined regimens of one year duration in the treatment of multibacillary leprosy--II. Combined regimens with rifampicin administered during 6 months.
Topics: Clinical Trials as Topic; Clofazimine; Cohort Studies; Dapsone; Drug Administration Schedule; Ethionamide; Female; Humans; Leprostatic Agents; Leprosy; Male; Rifampin | 1989 |
A double-blind controlled clinical trial to assess the role of anti-histamines in the treatment of multi-bacillary leprosy.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Clofazimine; Dapsone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Pheniramine | 1988 |
Efficacy of different regimens in multibacillary leprosy.
Topics: Clinical Trials as Topic; Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Ethionamide; Humans; Leprosy; Random Allocation; Rifampin | 1986 |
THELEP controlled clinical trials in lepromatous leprosy.
Topics: Animals; Clinical Trials as Topic; Clofazimine; Dapsone; Female; Humans; Leprostatic Agents; Leprosy; Male; Mice; Prothionamide; Rifampin | 1983 |
[Field experiences with therapy protocols in leprosy].
Topics: Clinical Trials as Topic; Clofazimine; Dapsone; Drug Administration Schedule; Humans; Leprostatic Agents; Leprosy; Prospective Studies; Rifampin | 1983 |
Hepatotoxicity of the combination of rifampin-ethionamide in the treatment of multibacillary leprosy.
Topics: Adolescent; Adult; Chemical and Drug Induced Liver Injury; Child; Clinical Trials as Topic; Clofazimine; Dapsone; Drug Therapy, Combination; Ethionamide; Female; Humans; Leprosy; Male; Middle Aged; Prospective Studies; Rifampin | 1984 |
Multidrug therapy for leprosy in Trinidad and Tobago: a preliminary report.
Topics: Acedapsone; Adolescent; Adult; Aged; Child; Child, Preschool; Clinical Trials as Topic; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Leprosy; Male; Middle Aged; Rifampin; Trinidad and Tobago | 1984 |
Effects of clofazimine alone or combined with dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy.
Topics: Candida albicans; Cell Movement; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Lymphocytes; Neutrophils; Phagocytosis | 1982 |
Long-term evaluation of immune status in leprosy patients undergoing multiple drug therapy.
Topics: Agglutination Tests; Antibodies, Bacterial; Antigens, Bacterial; Clofazimine; Dapsone; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Humans; Immunity, Cellular; Immunoglobulin M; Immunoglobulins; Leprostatic Agents; Leprosy; Longitudinal Studies; Lymphocyte Activation; Mycobacterium leprae; Rifampin; Skin Tests | 1994 |
Clinical trial of ofloxacin alone and in combination with dapsone plus clofazimine for treatment of lepromatous leprosy.
Topics: Adolescent; Adult; Animals; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Foot; Humans; Leprosy, Lepromatous; Male; Mice; Microbial Sensitivity Tests; Middle Aged; Mycobacterium leprae; Ofloxacin; Skin | 1994 |
Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen.
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Clofazimine; Crohn Disease; Dapsone; Double-Blind Method; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium Infections, Nontuberculous; Prospective Studies; Rifampin; Time Factors | 1994 |
A randomized clinical trial of two single-dose treatments for paucibacillary leprosy.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Ethionamide; Female; Humans; Infant; Leprosy; Male; Middle Aged; Prognosis; Recurrence; Rifampin | 1994 |
Reversal reaction in multibacillary leprosy patients following MDT with and without immunotherapy with a candidate for an antileprosy vaccine, Mycobacterium w.
Topics: Bacterial Vaccines; Clofazimine; Combined Modality Therapy; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Neuritis; Rifampin; Single-Blind Method | 1993 |
Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Erythema Nodosum; Humans; Interferon-gamma; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Mycobacterium leprae; Recombinant Proteins; Rifampin; Skin; Thalidomide | 1996 |
Ofloxacin-containing combined drug regimens in the treatment of lepromatous leprosy.
Topics: Adult; Animals; Anti-Infective Agents; Biopsy, Needle; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Mice; Ofloxacin; Treatment Outcome | 1994 |
Daily multidrug therapy for leprosy; results of a fourteen-year experience.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clofazimine; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Erythema Nodosum; Ethionamide; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Leprosy, Tuberculoid; Male; Middle Aged; Recurrence; Rifampin | 1997 |
Influence of acetylator phenotype on the haematological and biochemical effects associated with dapsone in leprosy patients.
Topics: Blood Cell Count; Blood Chemical Analysis; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Glucosephosphate Dehydrogenase; Humans; Leprostatic Agents; Leprosy; Male; Rifampin | 1997 |
Does clofazimine have a prophylactic role against neuritis?
Topics: Adolescent; Adult; Case-Control Studies; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Borderline; Male; Middle Aged; Neuritis | 1997 |
A multicenter study of recombinant interferon-alpha 2b in the treatment of multibacillary leprosy.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Erythema; Humans; Interferon Type I; Lepromin; Leprostatic Agents; Leprosy, Lepromatous; Recombinant Proteins; Rifampin | 1997 |
Immunochemotherapy with interferon-gamma and multidrug therapy for multibacillary leprosy.
Topics: Adolescent; Adult; Antibodies, Bacterial; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Interferon-gamma; Leprostatic Agents; Leprosy; Lymphocyte Activation; Male; Middle Aged; Neopterin; Recombinant Proteins; Rifampin; Skin | 1999 |
Effect of zafirlukast on leprosy reactions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Clofazimine; Cohort Studies; Dapsone; Erythema Nodosum; Female; Humans; Indoles; Leprostatic Agents; Leprosy; Leukotriene Antagonists; Male; Middle Aged; Nerve Degeneration; Phenylcarbamates; Prednisone; Rifampin; Sulfonamides; Thalidomide; Tosyl Compounds | 1999 |
Efficacy of WHO regimens in the management of leprosy patients with G6PD deficiency.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Oman; Practice Guidelines as Topic; Rifampin; World Health Organization | 1999 |
Induction of lepromin positivity following immuno-chemotherapy with Mycobacterium w vaccine and multidrug therapy and its impact on bacteriological clearance in multibacillary leprosy: report on a hospital-based clinical trial with the candidate antilepro
Topics: Bacterial Vaccines; Clofazimine; Dapsone; Double-Blind Method; Drug Therapy, Combination; Humans; Immunotherapy; Lepromin; Leprostatic Agents; Leprosy; Mycobacterium leprae; Rifampin; Single-Blind Method; Skin Tests; Vaccines, Inactivated | 1999 |
Long-term follow up of multibacillary leprosy patients with high BI treated with WHO/MDT regimen for a fixed duration of two years.
Topics: Adult; Clofazimine; Cohort Studies; Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy; Male; Neuritis; Recurrence; Rifampin; World Health Organization | 2000 |
Biochemical and hematological side effects of clofazimine in leprosy patients.
Topics: Blood Cell Count; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Rifampin | 2002 |
Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Minocycline; Ofloxacin; Rifampin | 2004 |
Relapses in multibacillary patients treated with multi-drug therapy until smear negativity: findings after twenty years.
Topics: Acedapsone; Aged; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; India; Leprostatic Agents; Leprosy, Lepromatous; Male; Microbial Sensitivity Tests; Mycobacterium leprae; Recurrence; Rifampin; World Health Organization | 2004 |
10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy.
Topics: Adenosine Triphosphate; Adolescent; Adult; Animals; BCG Vaccine; Biological Assay; Clofazimine; Combined Modality Therapy; Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; Foot; Humans; Immunization, Secondary; Immunotherapy; Leprostatic Agents; Leprosy, Lepromatous; Male; Mice; Middle Aged; Rifampin; Vaccination | 2004 |
International open trial of uniform multi-drug therapy regimen for 6 months for all types of leprosy patients: rationale, design and preliminary results.
Topics: Adolescent; Adult; Aged; Child; China; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; India; Leprostatic Agents; Leprosy; Male; Middle Aged; Rifampin; Skin Diseases, Bacterial; Treatment Outcome | 2008 |
Plasma levels of chemokines during leprosy specific treatment.
Topics: Adult; Aged; Chemokine CCL11; Chemokine CCL24; Chemokines; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Laboratories; Leprostatic Agents; Leprosy; Male; Middle Aged; Mycobacterium leprae; Rifampin; Treatment Outcome | 2010 |
Longitudinal ocular survey of 202 Filipino patients with multi-bacillary (MB) leprosy treated with 2 year WHO-multiple drug therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Clofazimine; Dapsone; Drug Therapy, Combination; Eye Diseases; Female; Humans; Infant; Leprostatic Agents; Leprosy, Multibacillary; Longitudinal Studies; Male; Middle Aged; Philippines; Prospective Studies; Rifampin; Young Adult | 2011 |
Brazilian clinical trial of uniform multidrug therapy for leprosy patients: the correlation between clinical disease types and adverse effects.
Topics: Adolescent; Adult; Aged; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy, Lepromatous; Leprosy, Multibacillary; Leprosy, Tuberculoid; Middle Aged; Prospective Studies; Rifampin; Young Adult | 2012 |
OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil.
Topics: Adolescent; Adult; Animals; Brazil; Clofazimine; Dapsone; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy, Multibacillary; Male; Mice; Middle Aged; Mycobacterium leprae; Ofloxacin; Prevalence; Rifampin; Secondary Prevention; Skin; Time Factors; Treatment Outcome; World Health Organization; Young Adult | 2012 |
Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brazil; Child; Child, Preschool; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Leprostatic Agents; Leprosy, Multibacillary; Male; Middle Aged; Recurrence; Rifampin; Time Factors; Treatment Outcome; Young Adult | 2017 |
Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach.
Topics: Adolescent; Adult; Anemia; Brazil; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Hemoglobins; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Rifampin; Risk Factors; Treatment Outcome; Young Adult | 2018 |
244 other study(ies) available for dapsone and clofazimine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Leprosy and the nervous system (author's transl)].
Topics: Adult; Antibody Formation; Central Nervous System Diseases; Clofazimine; Dapsone; Diagnosis, Differential; Female; Humans; Leprosy; Male; Motor Neurons; Neurologic Manifestations; Neuromuscular Diseases; Peripheral Nervous System Diseases; Rifampin | 1979 |
Management of sulphone-resistant lepromatous leprosy.
Topics: Clofazimine; Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Mycobacterium leprae; Thalidomide | 1977 |
The diagnosis and management of dapsone-resistant leprosy.
Topics: Clofazimine; Dapsone; Diagnosis, Differential; Drug Resistance, Microbial; Humans; Leprosy; Mycobacterium leprae; Rifampin | 1977 |
A rapid test for bacillary resistance to dapsone.
Topics: Clofazimine; Dapsone; Dihydroxyphenylalanine; Drug Resistance, Microbial; Mycobacterium leprae; Rifampin; Thymidine | 1978 |
Committee 4: workshop on experimental chemotherapy of leprosy.
Topics: Animals; Antitubercular Agents; Clofazimine; Dapsone; Drug Resistance, Microbial; Leprostatic Agents; Leprosy; Mice; Mycobacterium leprae; Rifampin; Sulfamethoxypyridazine | 1979 |
The treatment of leprosy today and tomorrow: the LEPRA consultation on chemotherapy.
Topics: Clofazimine; Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Mycobacterium leprae; Patient Compliance; Rifampin | 1977 |
Workshop on "chemotherapy of leprosy" at the Central Leprosy Teaching and Research Institute, Chengalpattu (Tamil Nadu) on 21 January 1978.
Topics: Clofazimine; Dapsone; Humans; India; Leprosy; Recurrence; Rifampin; Thalidomide | 1979 |
Treatment of steroid dependant cases of recurrent lepra reaction with a combination of thalidomide and clofazimine.
Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Male; Recurrence; Steroids; Thalidomide; Time Factors | 1979 |
Activity of some antileprosy compounds against Mycobacterium intracellulare in vitro.
Topics: Clofazimine; Culture Media; Dapsone; Drug Resistance, Microbial; Leprostatic Agents; Mycobacterium; Phenylthiourea | 1977 |
Leprosy and the rheumatoid factor.
Topics: Clofazimine; Dapsone; Humans; Leprosy; Rheumatoid Factor | 1978 |
Clofazimine in the treatment of dapsone resistant leprosy.
Topics: Clofazimine; Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Mycobacterium leprae | 1976 |
Lepromatous leprosy: dapsone resistance.
Topics: Clofazimine; Dapsone; Drug Resistance, Microbial; Female; Foot Deformities, Acquired; Humans; Leprosy; Middle Aged | 1976 |
The diagnosis and treatment of leprosy.
Topics: Biopsy; Clofazimine; Dapsone; Erythema Nodosum; Humans; Immunotherapy; Leprosy; Recurrence; Rifampin; Sensation; Skin; Thalidomide; United States | 1976 |
Treatment of Hansen's disease.
Topics: Chloroquine; Clofazimine; Dapsone; Drug Resistance, Microbial; Erythema Nodosum; Humans; Leprosy; Prednisone; Rifampin; Thalidomide | 1976 |
Transformation from lepromatous to borderline leprosy under clofazimine therapy.
Topics: Adult; Clofazimine; Dapsone; Humans; Leprosy; Male; Skin | 1976 |
Clinical trial with clofazimine in leprosy.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Middle Aged; Recurrence | 1976 |
Experiences in treatment of histoid cases with clofazimine.
Topics: Clofazimine; Dapsone; Humans; Leprosy | 1976 |
Side effects of clofazimine therapy.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Female; Humans; Ichthyosis; Isoniazid; Leprosy; Male; Skin Pigmentation | 1976 |
Viability of Myco. leprae in the skin and bone marrow of patients with lepromatous leprosy while on dapsone or lamprene.
Topics: Bone Marrow; Clofazimine; Dapsone; Humans; Leprosy; Mycobacterium leprae; Skin | 1975 |
Multicentre controlled comparative trial of clofazimine and dapsone in low dosages.
Topics: Clofazimine; Dapsone; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Leprosy; Mycobacterium leprae | 1975 |
Treatment of neuritis in borderline leprosy with rifampicin and corticosteroids--a pilot trial.
Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Neuritis; Pilot Projects; Prednisone; Rifampin | 1975 |
The drug treatment of leprosy.
Topics: Acute Disease; Adrenal Cortex Hormones; Aniline Compounds; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Rifampin; Thalidomide; Thiourea | 1975 |
Dapsone syndrome in Vanuatu: a high incidence during multidrug treatment (MDT) of leprosy.
Topics: Adolescent; Adult; Chemical and Drug Induced Liver Injury; Clofazimine; Dapsone; Drug Eruptions; Drug Synergism; Drug Therapy, Combination; Female; Humans; Incidence; Leprosy; Male; Middle Aged; Rifampin; Syndrome; Vanuatu | 1992 |
Leprosy in French Polynesia. The possible impact of multidrug therapy on epidemiological trends.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Ethionamide; Humans; Leprosy; Polynesia; Rifampin | 1992 |
[Therapy of lymphocytic infiltration].
Topics: Azathioprine; Clofazimine; Cyclosporine; Dapsone; Humans; Levamisole; Lymphocytosis; Skin; Skin Diseases; Thalidomide | 1992 |
Reconstruction of anti-leprosy drug depleted complement haemolytic activity by addition of zymosan-treated sera (a source of C142) and CratEDTA (a source of C3-C9).
Topics: Animals; Chloroquine; Clofazimine; Complement Activation; Complement System Proteins; Dapsone; Edetic Acid; Guinea Pigs; Hemolysis; Humans; Rats; Zymosan | 1992 |
Delayed clearance of circulating immune complexes in mice following administration of antileprosy drugs.
Topics: Animals; Antigen-Antibody Complex; Clofazimine; Dapsone; Kinetics; Leprostatic Agents; Male; Mice; Rifampin; Serum Albumin | 1992 |
Detection of Mycobacterium leprae and the potential for monitoring antileprosy drug therapy directly from skin biopsies by PCR.
Topics: Anti-Bacterial Agents; Biopsy; Clofazimine; Dapsone; DNA Probes; DNA, Bacterial; Drug Therapy, Combination; Electrophoresis, Agar Gel; Feasibility Studies; Humans; Leprosy; Mycobacterium leprae; Nucleic Acid Hybridization; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Skin | 1992 |
Ambulatory treatment of multibacillary leprosy with a regimen of 8 months duration.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Ethionamide; Humans; Leprostatic Agents; Leprosy | 1992 |
Effect of anti-leprosy drugs on superoxide anion production by rat peritoneal macrophage with special reference to light exposed clofazimine.
Topics: Animals; Clofazimine; Dapsone; In Vitro Techniques; Leprostatic Agents; Light; Macrophages; Mycobacterium leprae; Peritoneal Cavity; Rats; Rifampin; Staphylococcus aureus; Superoxides | 1991 |
Mechanisms by which clofazimine and dapsone inhibit the myeloperoxidase system. A possible correlation with their anti-inflammatory properties.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chlorides; Chromatography, High Pressure Liquid; Clofazimine; Dapsone; Humans; Hydrogen Peroxide; Hypochlorous Acid; NAD; Neutrophils; Oxidation-Reduction; Peroxidase; Thyroglobulin | 1991 |
Fatty acid oxidation and the beta-oxidation complex in Mycobacterium leprae and two axenically cultivable mycobacteria that are pathogens.
Topics: Acetyl Coenzyme A; Clofazimine; Dapsone; Fatty Acids; Laurates; Mycobacterium; Mycobacterium avium; Mycobacterium Infections; Mycobacterium leprae; Oxidation-Reduction; Rifampin | 1991 |
The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
Topics: Antibodies, Bacterial; Antigens, Bacterial; Carbohydrate Sequence; Clofazimine; Dapsone; Drug Therapy, Combination; Glycolipids; Humans; Immunoglobulin M; Leprostatic Agents; Leprosy; Leprosy, Borderline; Leprosy, Lepromatous; Molecular Sequence Data; Mycobacterium leprae; Rifampin; Skin; Time Factors | 1991 |
A retrospective study on seven years of multiple drug treatment for paucibacillary and multibacillary leprosy, in Bayara General Hospital, Nigeria.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Health Services Accessibility; Hospitals, General; Humans; Leprostatic Agents; Leprosy; Male; Nigeria; Patient Compliance; Recurrence; Retrospective Studies; Rifampin; Sex Factors | 1991 |
Impact of multidrug therapy on the treatment and control of leprosy.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Global Health; Humans; Leprosy; Patient Compliance; Rifampin | 1991 |
Clinical and bacteriological progress of highly bacillated BL-LL patients discontinuing treatment after different periods of MDT.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Borderline; Leprosy, Lepromatous; Middle Aged; Mycobacterium leprae; Rifampin; Time Factors | 1991 |
[Late reversal reactions in leprosy].
Topics: Clofazimine; Dapsone; Drug Combinations; Ethionamide; Female; Humans; Leprosy; Male; Recurrence; Rifampin | 1990 |
The chemotherapy of leprosy. Part 1.
Topics: Animals; Clofazimine; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Ethionamide; Humans; Leprosy; Mycobacterium leprae; Prothionamide; Rifampin | 1990 |
[Drugs used in tuberculosis and leprosy].
Topics: Administration, Oral; Antibiotics, Antitubercular; Clofazimine; Dapsone; Humans; Injections, Intramuscular; Isoniazid; Leprostatic Agents; Leprosy; Rifampin; Streptomycin; Tuberculosis | 1990 |
Simultaneous occurrence of upgrading and downgrading type 1 (lepra) reaction.
Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Borderline; Male; Rifampin; Time Factors | 1990 |
Effect of three-year multidrug therapy in multibacillary leprosy patients.
Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Leprosy, Borderline; Leprosy, Lepromatous; Male; Middle Aged; Rifampin | 1990 |
Susceptibilities of Mycobacterium leprae and M. avium complex to the H2O2-Fe-mediated halogenation system supplemented with antimicrobial agents.
Topics: Animals; Clofazimine; Dapsone; Ethidium; Ferrous Compounds; Fluoresceins; Humans; Hydrogen Peroxide; Iodides; Mice; Mycobacterium avium Complex; Mycobacterium leprae; Ofloxacin; Rifampin; Sodium Iodide; Staining and Labeling | 1989 |
Multiple cold abscesses in a borderline lepromatous patient on multidrug therapy.
Topics: Abscess; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Ethambutol; Hip Joint; Humans; Isoniazid; Leprosy, Borderline; Leprosy, Lepromatous; Male; Rifampin; Tuberculosis, Osteoarticular | 1989 |
Evaluation of Mycobacterium leprae antigens in the serological monitoring of a clofazimine-based chemotherapeutic study of dapsone resistant lepromatous leprosy patients in Cebu, Philippines.
Topics: Adult; Antigens, Bacterial; Clofazimine; Colony Count, Microbial; Dapsone; Drug Resistance, Microbial; Enzyme-Linked Immunosorbent Assay; Female; Humans; Leprosy, Lepromatous; Male; Middle Aged; Monitoring, Physiologic; Mycobacterium leprae; Philippines | 1989 |
Results of a modified WHO regimen in highly bacilliferous BL/LL patients.
Topics: Adenosine Triphosphate; Adolescent; Adult; Animals; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy, Borderline; Leprosy, Lepromatous; Mice; Middle Aged; Mycobacterium leprae; Rifampin | 1989 |
Bacillaemia in leprosy and effect of multidrug therapy.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Leprosy, Borderline; Leprosy, Lepromatous; Male; Middle Aged; Mycobacterium leprae; Rifampin; Sepsis; Skin | 1989 |
Vitiligo following type II lepra reaction.
Topics: Autoimmune Diseases; Clofazimine; Dapsone; Drug Therapy, Combination; Follow-Up Studies; Humans; Leprosy, Lepromatous; Male; Middle Aged; Rifampin; Vitiligo | 1989 |
Impact of multidrug therapy on leprosy in Baroda district (Gujarat).
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; India; Leprosy; National Health Programs; Patient Compliance; Rifampin | 1989 |
Evaluation of two multidrug regimen in hospitalised multibacillary cases.
Topics: Clofazimine; Dapsone; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Hospitalization; Humans; Leprosy; Rifampin | 1989 |
Comments on an editorial by B. R. Chatterjee "On Multi-Drug Combinations in the Treatment of Leprosy".
Topics: Animals; Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isonicotinic Acids; Leprosy; Mice; Prothionamide; Rifampin | 1989 |
Drug resistance and multi-drug therapy in leprosy.
Topics: Animals; Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprosy; Mice; Rifampin | 1989 |
Short-term multidrug therapy in multibacillary leprosy--review of 80 cases in two provinces of China (1983-1988).
Topics: Adult; China; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Leprosy, Borderline; Leprosy, Lepromatous; Male; Middle Aged; Retrospective Studies; Rifampin; Skin | 1989 |
Changing picture of leprosy in North Arcot District, Tamil Nadu after M.D.T.
Topics: Clofazimine; Cohort Studies; Dapsone; Drug Therapy, Combination; Follow-Up Studies; Humans; India; Leprosy, Borderline; Leprosy, Lepromatous; Leprosy, Tuberculoid; Recurrence; Rifampin | 1989 |
A follow up of T-cell subsets and of anti-M. leprae antibody titer as measured by the FLA-ABS test in Melanesian leprosy patients under polychemotherapy.
Topics: Adolescent; Adult; Antibodies, Bacterial; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Erythema Nodosum; Ethionamide; Fluorescent Antibody Technique; Humans; Leprosy; Middle Aged; Mycobacterium leprae; New Caledonia; Rifampin; T-Lymphocytes; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory | 1986 |
[Effect of rifampicin, clofazimine and dapsone in treating 296 cases of multibacillary leprosy].
Topics: Adolescent; Adult; Aged; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Middle Aged; Rifampin | 1987 |
Leprosy control based on multi drug treatment in India.
Topics: Allied Health Personnel; Clofazimine; Dapsone; Data Collection; Drug Administration Schedule; Drug Therapy, Combination; Humans; India; Leprosy; National Health Programs; Patient Compliance; Recurrence; Rifampin | 1988 |
Clofazimine and dapsone compliance in leprosy.
Topics: Clofazimine; Dapsone; Humans; Leprosy, Lepromatous; Patient Compliance; Pilot Projects; Rifampin; Self Administration | 1988 |
Multidrug therapy in hospitalised leprosy cases.
Topics: Adult; Clofazimine; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Rifampin | 1988 |
[Guinea: detection of leprosy and treatment by polychemotherapy].
Topics: Africa, Western; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Rifampin | 1988 |
On multi-drug combinations in the treatment of leprosy.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Ethionamide; Humans; Leprosy; Rifampin | 1988 |
Effect of multidrug therapy on the levels of antibodies to Mycobacterium leprae glycolipid-1 in the leprosy spectrum.
Topics: Antibodies, Bacterial; Antigens, Bacterial; Clofazimine; Dapsone; Drug Therapy, Combination; Glycolipids; Humans; Leprosy, Lepromatous; Radioimmunoassay; Rifampin | 1988 |
Paucibacillary leprosy: a comparative study of different schedules of multidrug therapy.
Topics: Adult; Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprosy; Male; Rifampin | 1988 |
Influence of once-monthly rifampicin and daily clofazimine on the pharmacokinetics of dapsone in leprosy patients in Nigeria.
Topics: Adolescent; Adult; Aged; Clofazimine; Dapsone; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Half-Life; Humans; Leprosy; Male; Middle Aged; Nigeria; Patient Compliance; Rifampin | 1988 |
Diagnosis of leprosy.
Topics: Clofazimine; Dapsone; Diagnosis, Differential; Drug Combinations; Humans; Leprosy; Rifampin | 1988 |
Drug interaction during multidrug regimens for treatment of leprosy.
Topics: Clofazimine; Dapsone; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Humans; Leprosy; Rifampin | 1988 |
New multidrug regimen with indigenous drugs and dapsone in the treatment of lepromatous leprosy (preliminary report).
Topics: Animals; Anti-Infective Agents; Clofazimine; Dapsone; Drug Therapy, Combination; Fatty Acids; Humans; Leprosy, Lepromatous; Mice; Plant Oils; Rifampin; Triterpenes | 1987 |
[Sulfone-resistance of Mycobacterium leprae--monotherapy with diaminodiphenylsulfone--the value of triple-drug combinations].
Topics: Clofazimine; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Leprosy; Mycobacterium leprae; Rifampin | 1986 |
Clofazimine-resistant M. leprae.
Topics: Animals; Clofazimine; Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Mice; Mycobacterium leprae | 1986 |
Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy.
Topics: Antibodies, Bacterial; Antigens, Bacterial; Clofazimine; Dapsone; Drug Therapy, Combination; Ethionamide; Glycolipids; Humans; Immunoglobulin G; Immunoglobulin M; Leprostatic Agents; Leprosy; Longitudinal Studies; Mycobacterium leprae; Rifampin; Time Factors | 1986 |
Combined clofazimine- and dapsone-resistant leprosy. A case report.
Topics: Adult; Animals; Clofazimine; Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Male; Mice; Mycobacterium leprae | 1986 |
[Therapy of leprosy today].
Topics: Clofazimine; Dapsone; Drug Resistance; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Rifampin | 1987 |
Combined chemotherapy of multibacillary leprosy of 6 months' duration.
Topics: Adolescent; Adult; Child; Child, Preschool; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Prothionamide; Recurrence; Rifampin | 1986 |
The future of leprosy in the Dominican Republic: experience with multidrug therapy.
Topics: Adolescent; Child; Child, Preschool; Clofazimine; Dapsone; Dominican Republic; Drug Therapy, Combination; Female; Humans; Infant; Leprostatic Agents; Leprosy; Male; Rifampin | 1986 |
Preliminary results of treatment of leprosy patients in The Netherlands with daily rifampicin, dapsone and clofazimine.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Netherlands; Recurrence; Rifampin | 1986 |
Effect of clofazimine and dapsone on rifampicin (Lositril) pharmacokinetics in multibacillary and paucibacillary leprosy cases.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Kinetics; Leprosy; Male; Middle Aged; Rifampin | 1986 |
Feasibility of multidrug therapy (MDT) in Hansen's disease in an urban population--Curupaiti State Hospital, Rio de Janeiro, Brazil.
Topics: Adolescent; Adult; Brazil; Clofazimine; Dapsone; Drug Therapy, Combination; Ethionamide; Female; Humans; Leprostatic Agents; Leprosy; Male; Patient Acceptance of Health Care; Patient Compliance; Prednisolone; Prothionamide; Rifampin; Urban Population | 1987 |
Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
Topics: Adult; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Edema; Erythema Nodosum; Ethionamide; Female; Humans; Leprostatic Agents; Leprosy; Male; Neuritis; Prospective Studies; Rifampin | 1986 |
Electrogustometry in Hansen's disease (study of 225 cases).
Topics: Adolescent; Adult; Ageusia; Clofazimine; Dapsone; Erythema Nodosum; Facial Paralysis; Female; Humans; Leprosy; Male; Rifampin; Taste Disorders | 1986 |
Monitoring dapsone self-administration in a multidrug therapy programme.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Ethiopia; Female; Humans; Leprosy; Male; Middle Aged; Patient Compliance; Rifampin; Self Administration | 1986 |
[Combination chemotherapy in leprosy].
Topics: Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Rifampin | 1986 |
The effect of clofazimine on the pharmacokinetics of rifampicin and dapsone in leprosy.
Topics: Clofazimine; Dapsone; Half-Life; Humans; Kinetics; Leprosy; Rifampin | 1986 |
Enhancement by clofazimine and inhibition by dapsone of production of prostaglandin E2 by human polymorphonuclear leukocytes in vitro.
Topics: Clofazimine; Dapsone; Dinoprostone; Female; Humans; In Vitro Techniques; Kinetics; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Prostaglandins E; Rifampin | 1985 |
Leprosy and the eye: a review.
Topics: Bacterial Vaccines; Clofazimine; Dapsone; Drug Therapy, Combination; Eye Diseases; Humans; Leprosy; Mycobacterium leprae; Rifampin | 1985 |
Recent trends in chemotherapy of leprosy.
Topics: Clofazimine; Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Isoniazid; Leprostatic Agents; Leprosy; Mycobacterium leprae; Prothionamide; Rifampin | 1985 |
Absence from sera from normal individuals or from rifampin-treated leprosy patients (THELEP trials) of antibody to rifamycin-protein or rifamycin-membrane conjugates.
Topics: Animals; Antibodies, Bacterial; Clofazimine; Coombs Test; Dapsone; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Erythrocyte Membrane; Humans; Immunoglobulin G; Immunoglobulin M; Leprosy; Lymphocytes; Mice; Rifampin; Rifamycins; Serum Albumin | 1985 |
Polytherapy in multibacillary leprosy patients in Nepal.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Prothionamide; Rifampin; Sex Ratio; Time Factors | 1985 |
Editorial: Problems and opportunities in the therapy of leprosy.
Topics: Clofazimine; Dapsone; Drug Resistance, Microbial; Humans; Leprostatic Agents; Leprosy; Rifampin | 1974 |
Thymus-dependent lymphocytes of peripheral blood in leprosy patients.
Topics: Adult; Aged; Animals; Blood Cell Count; Clofazimine; Dapsone; Erythema Nodosum; Erythrocytes; Humans; Immune Adherence Reaction; Leprosy; Middle Aged; Phenazines; Sheep; T-Lymphocytes | 1974 |
Fundamental data, methods and goals of present research on the treatment of leprosy.
Topics: Animals; Animals, Laboratory; Antitubercular Agents; Clofazimine; Dapsone; Ethionamide; Humans; In Vitro Techniques; Isoniazid; Leprosy; Mice; Mycobacterium lepraemurium; Rifampin; Sulfonamides; Trimethoprim | 1973 |
Dapsone resistance in leprosy.
Topics: Animals; Clofazimine; Dapsone; Drug Resistance, Microbial; Leprosy; Mice; Mycobacterium leprae; Rifampin | 1973 |
Evaluation of multiple regimens in leprosy.
Topics: Clofazimine; Dapsone; Drug Evaluation; Drug Therapy, Combination; Humans; Leprosy; Male; Rifampin; Sepsis; Thioacetazone | 1981 |
Multiple drug therapy--a comparative study with 2 tier and 3 tier combination of rifampicin, clofazimine, DDS, INAH and thiacetazone in lepromatous cases.
Topics: Adolescent; Adult; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Isoniazid; Leprosy; Male; Middle Aged; Rifampin; Thioacetazone | 1981 |
Evaluation of drug regimen in lepromatous leprosy--II.
Topics: Adult; Animals; Clofazimine; Dapsone; Drug Administration Schedule; Drug Resistance, Microbial; Humans; Isoniazid; Leprostatic Agents; Leprosy; Male; Mice; Middle Aged; Rifampin; Thioacetazone | 1983 |
Side-effects of antileprosy drugs in common use.
Topics: Clofazimine; Dapsone; Drug Hypersensitivity; Ethionamide; Humans; Leprostatic Agents; Leprosy; Rifampin; Thioacetazone | 1983 |
Intra-neural ceroid-like pigment following the treatment of lepromatous leprosy with clofazimine (B663; Lamprene).
Topics: Adult; Ceroid; Clofazimine; Dapsone; Drug Therapy, Combination; Histocytochemistry; Humans; Leprosy; Macrophages; Male; Peripheral Nerves; Peripheral Nervous System Diseases; Pigmentation Disorders; Pigments, Biological; Rifampin | 1981 |
The treatment of leprosy.
Topics: Adult; Animals; Clofazimine; Dapsone; Drug Resistance, Microbial; Erythema Nodosum; Ethionamide; Humans; Leprosy; Mycobacterium leprae; Patient Compliance; Prothionamide; Rifampin | 1983 |
How much non-infectious are the "non-infectious" lepromatous leprosy patients?
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Mycobacterium leprae; Nose; Rifampin | 1983 |
Leprosy today.
Topics: Clofazimine; Dapsone; Disease Models, Animal; Drug Resistance, Microbial; Humans; Leprosy; Mycobacterium leprae; Rifampin; Syndrome; T-Lymphocytes | 1983 |
Influence of agents with immunomodulating activity on phagocytosis and bactericidal function of human polymorphonuclear cells.
Topics: Adjuvants, Immunologic; Benzothiazoles; Blood Bactericidal Activity; Clofazimine; Cromolyn Sodium; Dapsone; Humans; Immunosuppressive Agents; Levamisole; Neutrophils; Phagocytosis; Phenylurea Compounds; Rifampin | 1983 |
Successful plasma exchange in type 1 leprosy reversal reaction.
Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Leukocyte Count; Male; Plasma Exchange; Rifampin; T-Lymphocytes | 1984 |
Treatment of leprosy in rural India as seen on a medical student elective.
Topics: Clofazimine; Dapsone; Developing Countries; Drug Therapy, Combination; Humans; India; Leprosy; Patient Compliance; Rifampin; Rural Population | 1984 |
New approaches to chemotherapy for leprosy.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Rifampin | 1983 |
Field application of combined therapy for infectious leprosy cases. A feasibility study in Bombay.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Evaluation; Drug Therapy, Combination; Humans; India; Leprosy; Middle Aged; Patient Compliance; Rifampin | 1983 |
Oral zinc in recurrent Erythema Nodosum Leprosum reaction.
Topics: Administration, Oral; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Erythema Nodosum; Female; Humans; Leprosy; Male; Middle Aged; Recurrence; Sulfates; Zinc; Zinc Sulfate | 1983 |
The effect of clofazimine on liver function tests in lepra reaction (ENL).
Topics: Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Blood Proteins; Clofazimine; Dapsone; Humans; Leprosy; Liver; Liver Function Tests | 1983 |
Chemotherapy of leprosy; "bubble" or "calendar" packs for the administration of rifampin, dapsone, clofazimine, or prothionamide/ethionamide.
Topics: Clofazimine; Dapsone; Drug Packaging; Ethionamide; Humans; Leprostatic Agents; Leprosy; Prothionamide; Rifampin; Tablets | 1983 |
Leprosy and its chemotherapy.
Topics: Clofazimine; Dapsone; Drug Resistance, Microbial; Humans; Leprosy; Mycobacterium leprae; Rifampin | 1982 |
Chemotherapy of leprosy for control programmes: scientific basis and practical application.
Topics: Clofazimine; Costs and Cost Analysis; Dapsone; Drug Resistance, Microbial; Humans; Leprostatic Agents; Leprosy; Prothionamide; Rifampin | 1983 |
Leprosy in Auckland.
Topics: Adult; Clofazimine; Dapsone; Female; Fiji; Humans; Independent State of Samoa; Leprosy; Male; New Zealand; Patient Compliance; Rifampin | 1980 |
Possible incompatibility of dapsone with clofazimine in the treatment of patients with erythema nodosum leprosum.
Topics: Clofazimine; Dapsone; Erythema Nodosum; Female; Humans; Leprosy; Male | 1982 |
Antileprosy drugs and lupus erythematosus.
Topics: Clofazimine; Dapsone; Humans; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic | 1982 |
Rifampin 1200 mg once monthly together with daily Lamprene and dapsone in treatment of refactory patients with lepromatous leprosy.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Middle Aged; Rifampin | 1981 |
Drug interactions -- the influence of rifampicin and clofazimine on the urinary excretion of DDS.
Topics: Clofazimine; Creatinine; Dapsone; Drug Interactions; Humans; Leprosy; Rifampin | 1981 |
Clofazimine (lamprene or B663) in lepra reactions.
Topics: Adult; Clofazimine; Dapsone; Female; Humans; Leprosy; Prednisolone | 1981 |
Determination of three main antileprosy drugs and their main metabolites in serum by high-performance liquid chromatography.
Topics: Animals; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Clofazimine; Dapsone; Guinea Pigs; Humans; Leprostatic Agents; Reference Values; Rifampin | 1981 |
A study of cell mediated immunity in leprosy.
Topics: Adolescent; Adult; Child; Clofazimine; Dapsone; Female; Humans; Immunity, Cellular; Leprostatic Agents; Leprosy; Male | 1981 |
Study on drug interactions.
Topics: Adult; Clofazimine; Dapsone; Drug Interactions; Drug Therapy, Combination; Humans; Isoniazid; Leprosy; Male; Middle Aged; Rifampin | 1980 |
Clofazimine and dapsone--a combination therapy in erythema nodosum leprosum syndrome.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Erythema Nodosum; Female; Humans; Leprosy; Male; Middle Aged | 1980 |
Leprosy.
Topics: Clofazimine; Dapsone; Drug Administration Schedule; Drug Resistance, Microbial; Humans; Leprostatic Agents; Leprosy; Rifampin | 1995 |
Midborderline (BB)-borderline lepromatous (BL) leprosy with reversal reaction (RR).
Topics: Aged; Biopsy; Clofazimine; Cyclosporine; Dapsone; Diabetes Complications; Humans; Leprosy, Lepromatous; Male; Neurologic Examination; Prednisone; Rifampin | 1994 |
Erythema elevatum diutinum.
Topics: Biopsy; Clofazimine; Dapsone; Erythema; Female; Fluorescent Antibody Technique; Hematologic Tests; Humans; Microscopy, Electron; Middle Aged | 1994 |
Treating Hansen's disease in developing countries.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprosy; Rifampin | 1994 |
Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
Topics: Adolescent; Adult; Aged; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Electrophysiology; Female; Humans; Leprosy; Leprosy, Borderline; Leprosy, Lepromatous; Leprosy, Tuberculoid; Male; Middle Aged; Neural Conduction; Peripheral Nerves; Reaction Time; Rifampin | 1993 |
Pedal edema following clofazimine therapy; a case report.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Edema; Foot Diseases; Humans; Leprosy, Borderline; Male; Middle Aged; Rifampin; Toes | 1993 |
Therapeutic efficacy of benzoxazinorifamycin, KRM-1648, in combination with other antimicrobials against Mycobacterium leprae infection induced in nude mice.
Topics: Animals; Clofazimine; Dapsone; Drug Therapy, Combination; Leprostatic Agents; Leprosy; Mice; Mice, Inbred BALB C; Mice, Nude; Rifamycins | 1994 |
Therapeutic monitoring and pharmacist intervention in a Hansen's disease clinic.
Topics: Academic Medical Centers; Chicago; Clofazimine; Dapsone; Drug Monitoring; Humans; Leprosy; Patient Care Team; Patient Compliance; Pharmacy Service, Hospital; Rifampin | 1993 |
Problems of leprosy relapse in China.
Topics: China; Clofazimine; Dapsone; Drug Therapy, Combination; Follow-Up Studies; Humans; Leprosy; Recurrence; Retrospective Studies; Rifampin; Risk Factors | 1993 |
Effects of chemotherapy on antibody levels directed against PGL-I and 85A and 85B protein antigens in lepromatous patients.
Topics: Antibodies, Bacterial; Antigens, Bacterial; Clofazimine; Dapsone; Drug Therapy, Combination; Glycolipids; Humans; Immunoglobulin G; Immunoglobulin M; Isoelectric Focusing; Leprostatic Agents; Leprosy, Lepromatous; Mycobacterium bovis; Mycobacterium leprae; Patient Compliance; Prothionamide; Rifampin | 1993 |
Efficacy and safety of multidrug therapy in paucibacillary leprosy in Singapore.
Topics: Adult; Aged; Aged, 80 and over; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Rifampin | 1993 |
Urinary excretion of renal brush border membrane enzymes in leprosy patients--effect of multidrug therapy.
Topics: Alkaline Phosphatase; Biomarkers; Clofazimine; Dapsone; Drug Monitoring; Drug Therapy, Combination; Follow-Up Studies; gamma-Glutamyltransferase; Humans; Kidney; Leprostatic Agents; Leprosy; Leucyl Aminopeptidase; Microvilli; Rifampin | 1996 |
Combined dapsone and clofazimine intoxication.
Topics: Adult; Charcoal; Clofazimine; Dapsone; Drug Overdose; Gastric Lavage; Humans; Leprostatic Agents; Male; Methemoglobinemia; Methylene Blue; Rifampin; Suicide, Attempted; Sulfates | 1996 |
Malignant pyoderma: a clinical variant of pyoderma gangrenosum.
Topics: Adrenal Cortex Hormones; Adult; Clofazimine; Dapsone; Female; Folliculitis; Humans; Pyoderma Gangrenosum; Skin; Vasculitis | 1996 |
Antileprosy drugs, pregnancy and fetal outcome.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Animals; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Leprostatic Agents; Leprosy; Mice; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Rats; Retrospective Studies; Rifampin | 1996 |
Primary resistance to single and multiple drugs in leprosy--a mouse footpad study.
Topics: Adult; Animals; Armadillos; Clofazimine; Dapsone; Drug Resistance, Microbial; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Mice; Microbial Sensitivity Tests; Mycobacterium leprae; Rifampin; Skin | 1996 |
Dapsone-induced motor polyneuropathy in a patient with leprosy.
Topics: Adult; Anti-Inflammatory Agents; Clofazimine; Dapsone; Diagnosis, Differential; Humans; Leprostatic Agents; Leprosy, Borderline; Male; Motor Neuron Disease; Prednisolone; Rifampin | 1997 |
Haematological and biochemical alterations in leprosy patients already treated with dapsone and MDT.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Methemoglobinemia; Rifampin | 1997 |
Studies on therapeutic activity of benzoxazinorifamycin KRM-1648 in combination with other antimicrobial agents and biological response modifiers interferon-gamma and granulocyte-macrophage colony-stimulating factor against M. leprae infection in athymic
Topics: Adoptive Transfer; Animals; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Immunologic Factors; Interferon-gamma; Leprostatic Agents; Leprosy; Mice; Mice, Inbred BALB C; Mice, Nude; Ofloxacin; Rifamycins | 1997 |
[Patient with Hansen disease and lepromatous reaction with predominant neural involvement].
Topics: Biopsy; Clofazimine; Dapsone; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Neuritis; Peripheral Nerves; Rifampin | 1998 |
[New WHO recommendations for the treatment of leprosy].
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Mycobacterium leprae; Ofloxacin; Rifampin; Skin | 1997 |
Leprosy.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Rifampin | 1997 |
Why multidrug therapy for multibacillary leprosy can be shortened to 12 months.
Topics: Clofazimine; Dapsone; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Rifampin; Time Factors; World Health Organization | 1998 |
Pro- and anti-oxidant effects of some antileprotic drugs in vitro and their influence on super oxide dismutase activity.
Topics: Antioxidants; Clofazimine; Dapsone; Dianisidine; Leprostatic Agents; Ofloxacin; Reactive Oxygen Species; Riboflavin; Rifampin; Superoxide Dismutase; Superoxides | 1998 |
Serum markers of treatment success in leprosy.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Biomarkers; Child; Clofazimine; Dapsone; Drug Therapy, Combination; E-Selectin; Female; Humans; Immunoglobulin G; Intercellular Adhesion Molecule-1; Leprostatic Agents; Leprosy; Male; Middle Aged; Mycobacterium leprae; Rifampin; Serum Albumin; Treatment Outcome | 1999 |
Histoid leprosy; report of three cases.
Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Rifampin | 1999 |
Risk factors for erythema nodosum leprosum.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Child; Child, Preschool; Clofazimine; Cohort Studies; Dapsone; Drug Therapy, Combination; Erythema Nodosum; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; Logistic Models; Male; Middle Aged; Mycobacterium leprae; Odds Ratio; Prevalence; Retrospective Studies; Risk Factors; Virulence | 1999 |
Nasal mucosa and skin of smear-positive leprosy patients after 24 months of fixed duration MDT: histopathological and microbiological study.
Topics: Adult; Animals; Biological Assay; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Histocytochemistry; Humans; Leprostatic Agents; Leprosy; Male; Mice; Middle Aged; Mycobacterium leprae; Nasal Mucosa; Rifampin; Skin | 1999 |
Antibacterial spectra of drugs used for chemotherapy of mycobacterial infections.
Topics: Aminosalicylic Acid; Antibiotics, Antitubercular; Bacillus subtilis; Capreomycin; Clofazimine; Dapsone; Drug Resistance, Microbial; Escherichia coli; Microbial Sensitivity Tests; Staphylococcus aureus; Viomycin | 1998 |
Generalized annular borderline tuberculoid leprosy and update in management of Hansen's disease.
Topics: Aged; Clofazimine; Dapsone; DNA, Bacterial; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Tuberculoid; Male; Mycobacterium leprae; Polymerase Chain Reaction; Rifampin | 2000 |
Ominous sign of a disfiguring disease. Leprosy (Hansen's disease).
Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Leprosy, Tuberculoid; Male; Rifampin; United States; Vietnam | 2000 |
Clofazimine: new products. Major antileprous drug.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Rifampin; Treatment Outcome; World Health Organization | 1999 |
Effect of treatment on PCR positivity in multibacillary leprosy patients treated with conventional and newer drugs ofloxacin and minocycline.
Topics: Adenosine Triphosphate; Biopsy; Clofazimine; Dapsone; DNA, Bacterial; Drug Evaluation; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Mycobacterium leprae; Ofloxacin; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Treatment Outcome | 1999 |
High prevalence of vitiligo in lepromatous leprosy.
Topics: Adult; Aged; Aged, 80 and over; Clofazimine; Dapsone; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Martinique; Middle Aged; Prevalence; Retrospective Studies; Rifampin; Thalidomide; Vitiligo | 2000 |
Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
Topics: Acedapsone; Adolescent; Adult; Animals; Child; Clofazimine; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; India; Leprostatic Agents; Leprosy, Lepromatous; Male; Mice; Mice, Inbred CBA; Mycobacterium leprae; Recurrence; Rifampin | 2000 |
Hansen's disease in a patient with a history of sarcoidosis.
Topics: Anti-Inflammatory Agents; Biopsy; Clofazimine; Dapsone; Dermatologic Agents; Electromyography; Female; Humans; Hydroxychloroquine; Leprostatic Agents; Leprosy, Tuberculoid; Lymphadenitis; Middle Aged; Mycobacterium leprae; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Prednisone; Reticulin; Rifampin; Sarcoidosis; Skin; Triamcinolone | 2000 |
Dapsone drug resistance in the MDT era.
Topics: Clofazimine; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Mycobacterium leprae; Nepal; Prevalence; Rifampin | 2000 |
Hansen's disease in a native-born, United States resident, after a brief stay in an endemic area abroad.
Topics: Aged; Cell Count; China; Clofazimine; Dapsone; Diabetes Mellitus, Type 1; Emigration and Immigration; Female; Hawaii; Humans; Leprosy; Mycobacterium leprae; Rifampin; United States | 2001 |
Lepromatous leprosy with drug reaction.
Topics: Clofazimine; Dapsone; Drug Eruptions; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Rifampin | 2000 |
A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Colony Count, Microbial; Dapsone; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Leprostatic Agents; Leprosy; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mycobacterium leprae; Ofloxacin; Rifampin | 2000 |
Assessment of antioxidant activity of some antileprotic drugs.
Topics: Adult; Antioxidants; Ascorbic Acid; Bepridil; Biphenyl Compounds; Clofazimine; Dapsone; Humans; Leprostatic Agents; Male; Oxidation-Reduction; Picrates; Rifampin; Spectrophotometry, Ultraviolet | 2001 |
Nodular rash in an Indonesian girl.
Topics: Adolescent; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Indonesia; Leprostatic Agents; Leprosy, Lepromatous; Rifampin; Skin; United States | 2001 |
[What is your diagnosis? Sensory motor polyneuropathy in borderline leprosy. Trophic skin disorders with ulcerations, local superinfection on the right foot with right inguinal lymphadenopathy].
Topics: Adolescent; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy, Borderline; Male; Rifampin; Time Factors | 2002 |
Treatment of Hansen's disease.
Topics: Clofazimine; Dapsone; Dermatomycoses; Diagnosis, Differential; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Rifampin; World Health Organization | 2002 |
Drug susceptibility of Mycobacterium leprae: a retrospective analysis of mouse footpad inoculation results from 1983 to 1997.
Topics: Adult; Animals; Clofazimine; Dapsone; Drug Resistance, Multiple, Bacterial; Female; Humans; India; Leprostatic Agents; Leprosy; Male; Mice; Middle Aged; Mycobacterium leprae; Retrospective Studies | 2002 |
Hansen's disease mimicking palmoplantar keratoderma.
Topics: Child; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Humans; Keratoderma, Palmoplantar; Leprostatic Agents; Leprosy, Lepromatous; Male; Rifampin | 2002 |
Short report: Treatment failure in Hansen's disease.
Topics: Adolescent; Adult; Aged; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Male; Medical Records; Middle Aged; Recurrence; Retrospective Studies; Rifampin; Texas; Treatment Failure; Treatment Refusal | 2003 |
Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Topics: Acedapsone; Adult; Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy; Male; Rifampin; Skin; Treatment Outcome; World Health Organization | 2003 |
Shiny red-brown papules in a 21-year-old man. Histoid leprosy.
Topics: Adult; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Face; Humans; Leprostatic Agents; Leprosy; Male; Rifampin; Skin Diseases; Thalidomide | 2004 |
DNA damage studies in untreated and treated leprosy patients.
Topics: Adolescent; Adult; Aged; Clofazimine; Dapsone; DNA Damage; Female; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Rifampin | 2004 |
Chemotherapy of leprosy.
Topics: Anti-Bacterial Agents; Clofazimine; Dapsone; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; HIV Infections; Humans; Hypersensitivity; India; Leprosy; Minocycline; Nausea; Ofloxacin; Rifampin; Secondary Prevention; Tuberculosis; World Health Organization | 2004 |
Dapsone syndrome with acute renal failure during leprosy treatment: case report.
Topics: Acute Kidney Injury; Adult; Clofazimine; Dapsone; Drug Hypersensitivity; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Rifampin; Syndrome | 2005 |
Borderline lepromatous leprosy presenting as a single cutaneous plaque.
Topics: Administration, Oral; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Forearm; Glucocorticoids; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Male; Prednisone; Recurrence; Rifampin; Skin; Treatment Outcome | 2005 |
Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
Topics: Adult; Anemia, Aplastic; Brazil; Clofazimine; Dapsone; Disease Progression; Drug Therapy, Combination; Fatal Outcome; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Rifampin; Risk Assessment; Severity of Illness Index | 2005 |
Remitting seronegative symmetrical synovitis with pitting edema in leprosy.
Topics: Aged; Clofazimine; Dapsone; Drug Therapy, Combination; Edema; Foot; Humans; Leprostatic Agents; Leprosy; Magnetic Resonance Imaging; Male; Methylprednisolone; Rifampin; Synovitis; Treatment Outcome | 2006 |
Renal hypersensitivity vasculitis associated with dapsone.
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Clofazimine; Cyclophosphamide; Dapsone; Drug Hypersensitivity; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Diseases; Leprostatic Agents; Leprosy; Methylprednisolone; Rifampin; Tuberculosis, Pulmonary; Vasculitis, Leukocytoclastic, Cutaneous | 2005 |
Chronic inflammatory joint disease revealing borderline leprosy.
Topics: Adult; Arthritis; Chronic Disease; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Electrophysiology; Humans; Leprostatic Agents; Leprosy, Borderline; Male; Musculoskeletal System; Neurons; Radiography; Rifampin; Toes | 2006 |
First report of leprosy presenting as acute polyarthritis in the setting of type I downgrading lepra reaction.
Topics: Acute Disease; Adult; Arthritis; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy, Borderline; Male; Mycobacterium leprae; Prednisolone; Treatment Outcome | 2006 |
[Dermopathy and peripheral neuropathy].
Topics: Aged; Clofazimine; Dapsone; Exanthema; Humans; Hypesthesia; Leprostatic Agents; Leprosy; Male; Rifampin; Spain; Venezuela | 2005 |
Epidemiology of leprosy and response to treatment in Hong Kong.
Topics: Clofazimine; Dapsone; Drug Resistance, Bacterial; Drug Therapy, Combination; Hong Kong; Humans; Incidence; Leprostatic Agents; Leprosy; Practice Guidelines as Topic; Recurrence; Retrospective Studies; Rifampin; Steroids; World Health Organization | 2006 |
[Guideline for the treatment of Hansen's disease in Japan (Second edition)].
Topics: Clofazimine; Congenital Abnormalities; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Japan; Leprostatic Agents; Leprosy; Rifampin; Surgical Procedures, Operative | 2006 |
Multidrug therapy regimen for leprosy.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Practice Guidelines as Topic; Rifampin; World Health Organization | 2006 |
An unusual rash in an elderly man.
Topics: Age Factors; Aged, 80 and over; Clofazimine; Dapsone; Diagnosis, Differential; Exanthema; Humans; Leprostatic Agents; Leprosy; Male; Rifampin | 2007 |
Multidrug therapy in leprosy.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Rifampin; World Health Organization | 2006 |
Leprosy in a preschool child--a case report.
Topics: Child, Preschool; Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Tuberculoid; Rifampin; Treatment Outcome | 2007 |
[Polyarthritis and papular eruption revealing leprosy].
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Arthritis; Biopsy; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Rifampin; Skin; Treatment Outcome | 2008 |
Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
Topics: Adult; Brazil; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Retrospective Studies; Rifampin; Treatment Outcome | 2007 |
Pure neural leprosy: steroids prevent neuropathy progression.
Topics: Adult; Aged; Clofazimine; Dapsone; Drug Therapy, Combination; Electrophysiology; Female; Follow-Up Studies; Glucocorticoids; Humans; Leprostatic Agents; Leprosy, Tuberculoid; Longitudinal Studies; Male; Middle Aged; Peripheral Nervous System Diseases; Prednisone; Prospective Studies; Rifampin; Treatment Outcome | 2007 |
Three indigenous cases of leprosy in the Mississippi delta.
Topics: Aged; Aged, 80 and over; Animals; Armadillos; Biopsy; Clofazimine; Dapsone; Diagnosis, Differential; Disease Reservoirs; Drug Therapy, Combination; Endemic Diseases; Female; Humans; Leprostatic Agents; Leprosy; Male; Mississippi; Mycobacterium leprae; Polymerase Chain Reaction; Rifampin; Skin; Zoonoses | 2008 |
Hansen's disease in Portugal: multibacillary patients treated between 1988 and 2003.
Topics: Aged; Anti-Bacterial Agents; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy; Middle Aged; Portugal; Prevalence; Retrospective Studies; Rifampin | 2009 |
Tuberculoid leprosy and Type 1 lepra reaction.
Topics: Adult; Biopsy; Clofazimine; Dapsone; Diagnosis, Differential; Humans; Leprostatic Agents; Leprosy, Tuberculoid; Male; Neural Conduction; Philippines; Rifampin; Sicily; Travel | 2008 |
[Sensory-motor neuropathy: a slow and misleading case of leprosy].
Topics: Adrenal Cortex Hormones; Aged; Aspirin; Clofazimine; Dapsone; Diagnosis, Differential; Female; Humans; Leprostatic Agents; Leprosy; Macrophages, Peritoneal; Mycobacterium lepraemurium; Rifampin | 2008 |
Type I reaction in a borderline leprosy case successfully treated with multidrug therapy and ofloxacin.
Topics: Anti-Bacterial Agents; Clofazimine; Dapsone; Drug Therapy, Combination; Glucocorticoids; Humans; Leprostatic Agents; Leprosy, Borderline; Male; Middle Aged; Ofloxacin; Prednisone; Rifampin | 2008 |
Autochthonous leprosy in metropolitan France presenting with a diffuse infiltration of the face and febrile illness.
Topics: Biopsy, Needle; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Facial Dermatoses; Female; Fever; Follow-Up Studies; France; Humans; Immunohistochemistry; Leg Dermatoses; Leprosy, Lepromatous; Middle Aged; Rifampin; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2009 |
Question: Can you identify this condition? Tuberculoid leprosy.
Topics: Adult; Asian People; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Tuberculoid; Mycobacterium leprae; Rifampin; Skin Diseases, Bacterial; Skin Tests | 2009 |
Leprosy: not always an easy diagnosis and often a management challenge.
Topics: Adult; Aged, 80 and over; Arm; Back; Clofazimine; Dapsone; Diagnosis, Differential; Drug Hypersensitivity; Drug Therapy, Combination; Face; Female; Forearm; Glucocorticoids; Humans; Leprostatic Agents; Leprosy, Borderline; Male; Mycobacterium leprae; Rifampin; Treatment Outcome | 2009 |
A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
Topics: Adolescent; Adult; Aged; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Nepal; Retrospective Studies; Rifampin; Treatment Outcome | 2008 |
Nonpruritic erythematous plaques.
Topics: Adult; Animals; Armadillos; Biopsy; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Erythema; Hand Dermatoses; Humans; Leprostatic Agents; Leprosy, Multibacillary; Male; Rifampin; Skin; Zoonoses | 2009 |
Agranulocytosis induced by multidrug therapy in leprosy treatment: a case report.
Topics: Adult; Agranulocytosis; Anemia, Hemolytic; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Rifampin | 2009 |
Lest we forget Hansen's disease (leprosy): an unusual presentation with an acute onset of inflammatory polyarthritis and the rheumatology experience.
Topics: Acute Disease; Aged; Arthritis; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Exanthema; Glucocorticoids; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Mycobacterium leprae; Peripheral Nerves; Peripheral Nervous System Diseases; Rifampin; Treatment Outcome | 2009 |
Minocycline is effective and cosmetically preferred to clofazimine by leprosy patients in New York.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Hyperpigmentation; Leprostatic Agents; Leprosy; Minocycline; New York; Patient Preference; Rifampin | 2010 |
Adverse effects of multi-drug therapy in leprosy, a two years' experience (2006-2008) in tertiary health care centre in the tribal region of Chhattisgarh State (Bastar, Jagdalpur).
Topics: Adolescent; Adult; Body Mass Index; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; India; Leprostatic Agents; Leprosy; Male; Prospective Studies; Rifampin; Risk Factors | 2011 |
Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
Topics: Animals; Bacterial Proteins; Biopsy; Clofazimine; Cross-Sectional Studies; Dapsone; Dihydropteroate Synthase; DNA Gyrase; Drug Resistance, Bacterial; Genetic Predisposition to Disease; Humans; Leprostatic Agents; Leprosy; Mice; Microbial Sensitivity Tests; Mutation; Mycobacterium leprae; Ofloxacin; Polymerase Chain Reaction; Rifampin | 2011 |
Relapse study in smear positive multibacillary (MB) leprosy after 1 year WHO-multi-drug therapy (MDT) in Cebu, Philippines.
Topics: Adolescent; Adult; Aged; Child; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Multibacillary; Male; Middle Aged; Philippines; Prospective Studies; Recurrence; Rifampin; Risk Factors; Time Factors; World Health Organization | 2011 |
Evaluation of multi-drug therapy for leprosy in the United States using daily rifampin.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Biopsy; Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Health Surveys; Humans; Leprostatic Agents; Leprosy; Male; Medical Records; Middle Aged; Retrospective Studies; Rifampin; Secondary Prevention; Treatment Outcome; United States | 2011 |
Facial reversal reaction: a dermatological emergency.
Topics: Adult; Antigens, CD; Antigens, Differentiation, Myelomonocytic; B-Lymphocytes; CD3 Complex; Clofazimine; Dapsone; Drug Therapy, Combination; Emergencies; Face; Facial Dermatoses; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Tuberculoid; Male; Prednisone; Receptors, Cell Surface; Rifampin; T-Lymphocytes; Treatment Outcome | 2012 |
A case of leprosy mistaken for cutaneous sarcoidosis.
Topics: Adult; Clofazimine; Dapsone; Diagnostic Errors; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Borderline; Rifampin; Sarcoidosis; Skin Diseases, Bacterial | 2012 |
Atypical Hansen's disease presenting as florid verrucous plaques on the lower extremities: a case report.
Topics: Biopsy; Clofazimine; Dapsone; Drug Therapy, Combination; Erythema Nodosum; Glucocorticoids; Humans; Leg Dermatoses; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Philippines; Prednisone; Rifampin | 2012 |
Florid reactive periostitis ossificans of long bones and digits associated with reaction in a patient with leprosy.
Topics: Adolescent; Clofazimine; Dapsone; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Osteitis; Periostitis; Radiography; Rifampin; Treatment Outcome | 2012 |
Dapsone induced eosinophilic pneumonia.
Topics: Aged; Biopsy; Clofazimine; Dapsone; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Pulmonary Eosinophilia; Rifampin | 2012 |
Clofazimine modulates the expression of lipid metabolism proteins in Mycobacterium leprae-infected macrophages.
Topics: Animals; Blotting, Western; Clofazimine; Dapsone; Gene Expression Profiling; Humans; Interferons; Leprostatic Agents; Lipid Metabolism; Macrophages; Mycobacterium leprae; Rats; Rats, Nude; Real-Time Polymerase Chain Reaction; Rifampin | 2012 |
Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally.
Topics: Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Mycobacterium leprae; Ofloxacin; Patient Compliance; Rifampin; World Health Organization | 2012 |
Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy.
Topics: Adolescent; Adult; Aged; Anemia, Hemolytic; Brazil; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; Hematocrit; Hematologic Tests; Hemoglobins; Hemolysis; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Retrospective Studies; Rifampin; Treatment Outcome; World Health Organization; Young Adult | 2012 |
A young man with livid facial nodules and a loss of eyebrows.
Topics: Adult; Alopecia; Clofazimine; Dapsone; Eyebrows; Facial Dermatoses; Humans; Leprostatic Agents; Leprosy, Multibacillary; Male; Rifampin | 2013 |
[Histoid leprosy].
Topics: Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Granuloma; Guinea; Histiocytes; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Morocco; Rifampin; Staining and Labeling | 2013 |
An under-recognized cause of polyarthritis: leprosy.
Topics: Anti-Inflammatory Agents; Arthritis; Arthritis, Rheumatoid; Clofazimine; Dapsone; Delayed Diagnosis; Diagnosis, Differential; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Prednisolone; Rifampin; Treatment Outcome | 2013 |
A case of Hansen Disease presenting as tinea versicolor.
Topics: Clofazimine; Contraindications; Dapsone; Delayed Diagnosis; Diagnostic Errors; Humans; Hypesthesia; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Male; Minocycline; Mycobacterium leprae; Rifampin; Tinea Versicolor; Young Adult | 2013 |
Clinical oxidative stress during leprosy multidrug therapy: impact of dapsone oxidation.
Topics: Adult; Analysis of Variance; Catalase; Clofazimine; Cytochrome P-450 CYP2C19; Dapsone; Drug Therapy, Combination; Female; Glutathione; Heinz Bodies; Humans; Leprostatic Agents; Leprosy; Male; Methemoglobin; Middle Aged; Oxidation-Reduction; Oxidative Stress; Protein Binding; Reactive Oxygen Species; Rifampin; Time Factors; Treatment Outcome; Young Adult | 2014 |
[Borderline lepromatous leprosy].
Topics: Adult; Biopsy; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprosy, Borderline; Leprosy, Lepromatous; Leprosy, Multibacillary; Morocco; Neglected Diseases; Rifampin; Skin | 2014 |
Optic nerve involvement in a borderline lepromatous leprosy patient on multidrug therapy.
Topics: Anti-Inflammatory Agents; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; India; Leprostatic Agents; Leprosy, Borderline; Male; Middle Aged; Ophthalmoscopy; Optic Disk; Optic Nerve; Prednisolone; Rifampin; Visual Acuity; Visual Field Tests | 2013 |
Leprosy.
Topics: Aged, 80 and over; Clofazimine; Dapsone; Humans; Leprostatic Agents; Leprosy; Male; Mycobacterium leprae; Rifampin; Skin; Treatment Outcome | 2014 |
Six years' follow-up of multibacillary leprosy patients treated with uniform multi-drug therapy in China.
Topics: Adolescent; Adult; Aged; Child; China; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy, Multibacillary; Male; Middle Aged; Rifampin; Skin; Treatment Outcome; Young Adult | 2015 |
A man with facial changes.
Topics: Clofazimine; Dapsone; Facies; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Mycobacterium leprae; Nasal Septal Perforation; Nasal Septum; Peripheral Nervous System Diseases; Rifampin; Treatment Outcome; Young Adult | 2014 |
Borderline Lepromatous Leprosy with Type 1 (Reversal) Reactions in a Chinese Man.
Topics: Clofazimine; Dapsone; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Male; Middle Aged; Mycobacterium leprae; Rifampin | 2015 |
Diffuse Lepromatous Leprosy Due to Mycobacterium lepromatosis in Quintana Roo, Mexico.
Topics: Adult; Base Sequence; Clofazimine; Dapsone; DNA, Bacterial; Drug Combinations; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; Mexico; Mycobacterium; Rifampin; RNA, Ribosomal, 16S; Sequence Analysis, DNA | 2015 |
Leproma Presenting as a Nasal Cavity Mass.
Topics: Biopsy; Clofazimine; Dapsone; Diagnosis, Differential; Endoscopy; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy, Lepromatous; Middle Aged; Nasal Cavity; Nasal Obstruction; Olfaction Disorders; Rifampin; Tissue Adhesions | 2015 |
Wade histoid leprosy revisited.
Topics: Adolescent; Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Rifampin | 2016 |
Leprosy in the UK.
Topics: Clofazimine; Dapsone; Humans; Leprostatic Agents; Leprosy; Peripheral Nervous System Diseases; Rifampin; United Kingdom | 2016 |
Painless Nodular Rash in a Young Man.
Topics: Adult; Clofazimine; Dapsone; Diagnosis, Differential; Exanthema; Humans; Leprostatic Agents; Leprosy; Male; Mycobacterium leprae; Patient Care Management; Rifampin; Skin | 2017 |
Chronic, persistent angioedema and sinusitis-like presentation of multibacillary leprosy.
Topics: Adolescent; Angioedema; Biopsy; Chronic Disease; Clofazimine; Dapsone; Developing Countries; Diagnosis, Differential; Drug Therapy, Combination; Facial Dermatoses; Follow-Up Studies; Humans; India; Leprosy, Multibacillary; Male; Rifampin; Sinusitis; Skin | 2018 |
A Traditional NSAID Aspirin along with Clofazimine in Erythema Nodosum Leprosum Reaction: Study of Six Cases.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clofazimine; Dapsone; Drug Therapy, Combination; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy; Male; Young Adult | 2016 |
Nanosystems as modulators of intestinal dapsone and clofazimine delivery.
Topics: Caco-2 Cells; Cell Survival; Clofazimine; Dapsone; Drug Delivery Systems; Electric Impedance; Humans; Intestines; Nanoparticles | 2018 |
Chromatographic method for the simultaneous quantification of dapsone and clofazimine in nanoformulations.
Topics: Chromatography, High Pressure Liquid; Clofazimine; Dapsone; Molecular Structure; Nanostructures | 2018 |
Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.
Topics: American Samoa; Biopsy; Clofazimine; Dapsone; Drug Administration Schedule; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Leprostatic Agents; Leprosy; Microbial Sensitivity Tests; Mutation; Mycobacterium leprae; Rifampin; Skin | 2018 |
Multiple livid-erythematous macules and plaques with slight scaling in a young man.
Topics: Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Erythema; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Rifampin; Treatment Outcome; Young Adult | 2018 |
Evaluation of Prospective HLA-B*13:01 Screening to Prevent Dapsone Hypersensitivity Syndrome in Patients With Leprosy.
Topics: Adult; Alleles; China; Clofazimine; Cohort Studies; Dapsone; Drug Hypersensitivity Syndrome; Drug Therapy, Combination; Female; HLA-B13 Antigen; Humans; Incidence; Leprostatic Agents; Leprosy; Male; Middle Aged; Prospective Studies; Rifampin | 2019 |
4,4'-Diaminodiphenyl Sulfone (DDS) as an Inflammasome Competitor.
Topics: Alzheimer Disease; Clofazimine; Cognitive Dysfunction; Coronavirus Infections; COVID-19; Dapsone; Humans; Inflammasomes; Interleukin-1beta; Leprosy; NLR Family, Pyrin Domain-Containing 3 Protein; Pandemics; Parkinsonian Disorders; Pneumonia, Viral; Rifampin; Spike Glycoprotein, Coronavirus; Toll-Like Receptor 2 | 2020 |
Lepromatous leprosy presenting with type II reaction before and type I reaction after treatment.
Topics: Clofazimine; Dapsone; Disease Progression; Drug Therapy, Combination; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Rifampin; Treatment Outcome | 2020 |
Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia.
Topics: Adolescent; Adult; Alleles; Biomarkers; Case-Control Studies; Clofazimine; Dapsone; Drug Hypersensitivity; Drug Therapy, Combination; Female; HLA-B13 Antigen; Humans; Indonesia; Leprostatic Agents; Leprosy; Logistic Models; Male; Rifampin; Risk Assessment; Syndrome; Young Adult | 2020 |
Low rate of relapse after twelve-dose multidrug therapy for hansen's disease: A 20-year cohort study in a brazilian reference center.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brazil; Child; Child, Preschool; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Incidence; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Mycobacterium leprae; Recurrence; Retrospective Studies; Rifampin; Skin; Young Adult | 2021 |
The influence of leprosy-related clinical and epidemiological variables in the occurrence and severity of COVID-19: A prospective real-world cohort study.
Topics: Adrenal Cortex Hormones; BCG Vaccine; Brazil; Clofazimine; Cohort Studies; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Dapsone; Humans; Leprosy; Pentoxifylline; Prospective Studies; Risk Factors; SARS-CoV-2; Survival Analysis; Thalidomide | 2021 |
Interaction of constituents of MDT regimen for leprosy with Mycobacterium leprae HSP18: impact on its structure and function.
Topics: Antigens, Bacterial; Bacterial Proteins; Clofazimine; Dapsone; Heat-Shock Proteins; Host-Pathogen Interactions; Humans; Hydrophobic and Hydrophilic Interactions; Leprostatic Agents; Leprosy; Molecular Chaperones; Mycobacterium leprae; Protein Binding; Protein Structure, Secondary; Rifampin | 2022 |
Multibacillary Mid-Borderline Leprosy with Type 1 Lepra Reaction and Concurrent Latent Tuberculosis.
Topics: Abattoirs; Anti-Inflammatory Agents; Antitubercular Agents; Clofazimine; Dapsone; Diagnosis, Differential; Humans; Isoniazid; Latent Tuberculosis; Leprostatic Agents; Leprosy, Borderline; Leprosy, Multibacillary; Male; Middle Aged; Prednisolone; Rifampin; Thrombophlebitis | 2021 |